STOCK TITAN

Axe Compute (NASDAQ: AGPU) grows AI revenue but posts $24.9M loss on ATH slide

(Moderate)
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Axe Compute Inc. reported rapid top-line growth but much larger losses as it pivots into AI compute services supported by crypto assets. Revenue for the six months ended June 30, 2026 rose to $3.3 million from $0.1 million, driven by GPU compute contracts rather than the legacy drug discovery business.

The company posted a six‑month net loss of $24.9 million versus $4.5 million a year earlier, mainly due to $17.4 million of losses on ATH digital assets held in its Strategic Compute Reserve and higher operating expenses. Cash and cash equivalents were $21.9 million, with digital assets at $11.3 million, and management believes liquidity is sufficient for at least 12 months.

Contract liabilities climbed to $60.8 million, reflecting prepaid GPU services, with remaining performance obligations scheduled through 2029. In April 2026 Axe signed a $260 million, 36‑month NVIDIA B300 infrastructure contract and in July 2026 secured three additional contracts totaling over $2.8 billion, while also taking on $262.6 million in multi‑year compute purchase commitments.

Positive

  • Revenue grew to $3.3 million for the first half of 2026 from $0.1 million a year earlier, reflecting early traction in the GPU compute services business.
  • Contract liabilities reached $60.8 million, providing visibility into future revenue from prepaid compute service obligations extending through 2029.
  • In April 2026 the company signed a $260 million, 36‑month NVIDIA B300 infrastructure contract, underpinning long‑term AI compute demand.
  • In July 2026 Axe Compute secured three new contracts exceeding $2.8 billion in total value, significantly expanding its AI infrastructure pipeline.
  • Cash of $21.9 million plus $11.3 million of digital assets and access to an $83 million ATM facility support near‑term liquidity needs.

Negative

  • Net loss widened to $24.9 million for the first half of 2026 from $4.5 million, driven by digital asset losses and higher operating costs.
  • The company recorded $17.4 million in losses on ATH digital assets, and fair value fell to $11.1 million versus a $94.7 million cost basis, highlighting substantial volatility.
  • Compute purchase commitments total $262.6 million through 2029, a large fixed obligation relative to $100.4 million of total assets.
  • A digital asset receivable embeds a $83.1 million derivative liability, adding complexity and exposure to ATH‑related valuation changes.
  • Customer concentration is high: in the second quarter of 2026, one customer represented 49% and another 27% of revenue, and together they comprised a majority of accounts receivable.

Filing Explained

As of June 30, 2026, 9,972,424 pre-funded warrants were exercisable and $83.0 million of ATM capacity remained, preserving two dilution routes.

Axe Compute Inc.’s Form 10-Q, an unaudited quarterly report, shows that as of August 13, 2026 the company had $11,591,124 shares of common stock outstanding. It also reports 9,972,424 pre-funded warrants remained vested and exercisable without expiration; exercise would increase the share count and dilute existing holders’ percentage ownership.

These warrants remain warrants rather than issued common shares, but their nominal $0.01 exercise price means they can convert into common shares when exercised.

Separately, the ATM arrangement left $83.0 million available for future sales as of June 30, 2026; that figure is issuance capacity, not proceeds already received, although the company reported approximately $10.3 million of net ATM proceeds during the quarter.

Note 11 therefore identifies two distinct future-state routes for additional common shares: exercise of the outstanding pre-funded warrants and sales under the ATM facility.

Revenue (six months 2026) $3,250,303 Six months ended June 30, 2026 compared to $112,992 in 2025
Net loss (six months 2026) $24,914,825 Six months ended June 30, 2026 compared to $4,513,335 in 2025
Losses on digital assets $17,421,620 Six months ended June 30, 2026, primarily related to ATH holdings
Cash and cash equivalents $21,905,767 Balance at June 30, 2026
ATH fair value vs cost basis $11,144,775 fair value on $94,739,253 cost ATH holdings as of June 30, 2026
Contract liabilities $60,754,672 Prepaid compute service obligations as of June 30, 2026
Compute service commitments $262,575,515 Total GPU, storage, networking and support commitments through 2029
April 2026 NVIDIA contract value $260,000,000 36‑month enterprise infrastructure agreement announced April 22, 2026
Strategic Compute Reserve financial
"Under this strategy, the Company maintains a Strategic Compute Reserve comprised primarily of ATH"
A strategic compute reserve is a dedicated pool of computing power—such as servers, GPUs, or cloud capacity—set aside to handle high-priority tasks, emergencies, or sudden demand spikes. For investors, it matters because maintaining this reserve requires spending and affects a company's ability to stay reliable, scale quickly, and protect critical operations; like keeping a backup generator, it trades ongoing cost for reduced downtime and competitive stability.
contract liabilities financial
"As of June 30, 2026, the Company had contract liabilities of $60.7 million primarily related to compute services"
Contract liabilities are amounts a company has been paid in advance for goods or services it still owes to customers — think of them like gift cards or prepaid subscriptions the company must fulfill later. For investors, they show promised future work or deliveries that will turn into revenue over time, reveal cash already collected, and help assess whether a firm has a backlog of obligations that could affect future earnings and cash flow.
Simple Agreements for Future Tokens (“SAFTs”) financial
"Locked ATH was obtained pursuant to Simple Agreements for Future Tokens (“SAFTs”)"
embedded derivative financial
"consisting of a host receivable of $93.4 million, net of an embedded derivative liability"
An embedded derivative is a built-in feature inside a contract—like a bond, loan, or lease—that causes part of the payout to change based on something else, such as a stock price, interest rate, or commodity price. It matters to investors because that hidden feature can add separate risk and volatility to a security’s value and accounting treatment, like finding a removable engine in a car that changes how fast it can go and how much it’s worth.
at-the-market (“ATM”) sales agreement financial
"the Company entered into an at-the-market (“ATM”) sales agreement with Wainwright & Co., LLC"
Level 3 financial
"the embedded derivative related to digital asset receivable is classified as Level 3"
Level 3 describes the lowest-confidence category in the accounting “fair value” hierarchy, covering assets or liabilities whose prices are not observable in the market and must be estimated using judgment and internal models. For investors, Level 3 items matter because they can introduce greater uncertainty and potential valuation swings—like valuing a unique antique versus checking a price tag on a supermarket shelf—so they signal higher model risk and lower liquidity.
Revenue (six months) $3,250,303 vs $112,992 prior-year period increased versus prior-year period
Net loss (six months) $24,914,825 vs $4,513,335 prior-year period loss increased versus prior-year period
Losses on digital assets (six months) $17,421,620 vs $0 prior-year period new loss category driven by ATH holdings

FAQ

How did Axe Compute (AGPU) perform financially in the first half of 2026?

Axe Compute reported $3.3 million in revenue and a $24.9 million net loss for the six months ended June 30, 2026. Results reflect early GPU compute revenue, $17.4 million in digital asset losses, and higher general, administrative, and sales expenses.

What is Axe Compute’s exposure to ATH and other digital assets?

The company held ATH with fair value of $11.1 million at June 30, 2026 on a $94.7 million cost basis, plus about $0.1 million of other tokens. It also recorded a $10.3 million digital asset receivable net of an $83.1 million embedded derivative liability tied to ATH vesting.

What major contracts has Axe Compute (AGPU) signed for AI infrastructure?

In April 2026 Axe signed a $260 million, 36‑month contract to deliver 2,304 NVIDIA B300 GPUs and storage from a U.S. Tier 3 facility. In July 2026 it secured three additional contracts with total contract value exceeding $2.8 billion across the U.S. and Europe.

What is Axe Compute’s liquidity position as of June 30, 2026?

As of June 30, 2026 Axe held $21.9 million in cash and cash equivalents and $11.3 million in digital assets. It also has roughly $83.0 million available under an at‑the‑market equity program and a $10.0 million standby equity purchase agreement.

How large are Axe Compute’s future obligations for GPU capacity and services?

Service commitments for GPU compute, storage, networking, and support total $262.6 million through 2029. Scheduled payments are $16.8 million in the remainder of 2026, $107.7 million in 2027, $99.2 million in 2028, and $38.9 million in 2029.

What are Axe Compute’s remaining performance obligations from customer prepayments?

Contract liabilities were $60.8 million at June 30, 2026, all tied to compute services. The company expects to recognize $29.3 million of this in the rest of 2026, $7.1 million in 2027, $1.9 million in 2028, and $22.5 million in 2029.

How concentrated is Axe Compute’s customer base in 2026?

In the quarter ended June 30, 2026, Customer A represented 49% and Customer B 27% of revenue. At that date they accounted for 16% and 13% of accounts receivable, while Customer C comprised 58% of accounts receivable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
Q2 2026 --12-31 false 0001446159 2 2 0 0 3 0 0 10 3 0 0 10 10 0 0 0 0 0 1 1 1 0.5 15 0.01 0.01 0.01 0.01 00014461592026-01-012026-06-30 thunderdome:item iso4217:USD 0001446159us-gaap:SubsequentEventMember2026-07-01 00014461592025-01-012025-06-30 00014461592025-04-012025-06-30 00014461592026-04-012026-06-30 0001446159us-gaap:CorporateNonSegmentMember2025-01-012025-06-30 0001446159us-gaap:CorporateNonSegmentMember2026-01-012026-06-30 0001446159us-gaap:CorporateNonSegmentMember2025-04-012025-06-30 0001446159us-gaap:CorporateNonSegmentMember2026-04-012026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2025-01-012025-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2026-01-012026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2025-04-012025-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2026-04-012026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2025-01-012025-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2026-01-012026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2025-04-012025-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2026-04-012026-06-30 00014461592025-01-012025-12-31 00014461592025-12-31 00014461592026-06-30 0001446159us-gaap:CorporateNonSegmentMember2025-01-012025-12-31 0001446159us-gaap:CorporateNonSegmentMember2025-12-31 0001446159us-gaap:CorporateNonSegmentMember2026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2025-01-012025-12-31 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2025-12-31 0001446159us-gaap:OperatingSegmentsMemberagpu:DrugDiscoveryServicesSegmentMember2026-06-30 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2025-01-012025-12-31 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2025-12-31 0001446159us-gaap:OperatingSegmentsMemberagpu:ComputeServicesAndTreasuryManagementSegmentMember2026-06-30 xbrli:pure xbrli:shares 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-01-012025-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-01-012026-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-04-012025-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-04-012026-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-04-012025-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-04-012026-06-30 0001446159us-gaap:WarrantMember2025-01-012025-06-30 0001446159us-gaap:WarrantMember2026-01-012026-06-30 0001446159us-gaap:WarrantMember2025-04-012025-06-30 0001446159us-gaap:WarrantMember2026-04-012026-06-30 0001446159us-gaap:EmployeeStockOptionMember2025-01-012025-06-30 0001446159us-gaap:EmployeeStockOptionMember2026-01-012026-06-30 0001446159us-gaap:EmployeeStockOptionMember2025-04-012025-06-30 0001446159us-gaap:EmployeeStockOptionMember2026-04-012026-06-30 iso4217:USDxbrli:shares 0001446159agpu:PrefundedWarrantsMember2026-06-30 utr:Y 0001446159us-gaap:EmployeeStockOptionMember2026-01-012026-06-30 0001446159us-gaap:EmployeeStockOptionMember2026-06-30 0001446159us-gaap:EmployeeStockOptionMember2025-06-302025-06-30 00014461592026-06-302026-06-30 0001446159us-gaap:EmployeeStockOptionMember2026-06-302026-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-06-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-12-31 0001446159us-gaap:RestrictedStockUnitsRSUMembersrt:ChiefExecutiveOfficerMember2025-12-102025-12-10 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-09-092025-09-09 0001446159us-gaap:EmployeeStockOptionMembersrt:MaximumMember2026-01-012026-06-30 0001446159agpu:StockWarrantsMember2025-01-012025-06-30 0001446159agpu:StockWarrantsMember2026-01-012026-06-30 0001446159agpu:StockWarrantsMember2026-06-30 0001446159agpu:StockWarrantsMember2026-01-012026-06-30 0001446159agpu:StockWarrantsMember2025-12-31 0001446159agpu:PrefundedWarrantMember2026-06-30 0001446159agpu:PrefundedWarrantMember2026-01-012026-06-30 0001446159agpu:CryptoPIPEWarrantsMember2025-10-07 0001446159agpu:CashPIPESPAMember2025-10-07 0001446159agpu:CashPIPEWarrantsMember2025-10-07 0001446159agpu:CashPIPESPAMember2025-10-072025-10-07 0001446159agpu:SalesAgreementMember2026-06-30 0001446159agpu:SalesAgreementMember2026-05-15 0001446159agpu:SalesAgreementMember2026-01-012026-06-30 0001446159agpu:SalesAgreementMember2024-05-032026-05-13 0001446159agpu:SalesAgreementMember2026-04-012026-04-30 0001446159agpu:SalesAgreementMember2026-04-30 0001446159agpu:SalesAgreementMember2025-10-29 0001446159agpu:SalesAgreementMember2025-09-30 0001446159agpu:SalesAgreementMember2025-06-02 0001446159agpu:SalesAgreementMember2025-05-31 0001446159agpu:SalesAgreementMember2025-04-18 0001446159agpu:SalesAgreementMember2024-05-03 0001446159agpu:InsurancePolicyFinancingMember2025-12-31 0001446159agpu:InsurancePolicyFinancingMember2025-06-30 0001446159agpu:InsurancePolicyFinancingMember2025-06-302025-06-30 0001446159agpu:InsurancePolicyFinancingMember2026-06-30 0001446159agpu:InsurancePolicyFinancingMember2026-06-302026-06-30 0001446159agpu:ComputeAgreementsMember2026-06-30 utr:M 0001446159srt:MaximumMemberagpu:ComputeAgreementsMember2026-04-012026-06-30 0001446159srt:MinimumMemberagpu:ComputeAgreementsMember2026-04-012026-06-30 0001446159us-gaap:PropertyPlantAndEquipmentMember2025-01-012025-03-31 0001446159us-gaap:PropertyPlantAndEquipmentMember2026-01-012026-03-31 0001446159us-gaap:EquipmentMember2026-04-012026-06-30 0001446159agpu:LaboratoryEquipmentMember2025-12-31 0001446159agpu:LaboratoryEquipmentMember2026-06-30 0001446159us-gaap:LeaseholdImprovementsMember2025-12-31 0001446159us-gaap:LeaseholdImprovementsMember2026-06-30 0001446159us-gaap:TechnologyEquipmentMember2025-12-31 0001446159us-gaap:TechnologyEquipmentMember2026-06-30 0001446159us-gaap:OfficeEquipmentMember2025-12-31 0001446159us-gaap:OfficeEquipmentMember2026-06-30 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2025-12-31 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2025-12-31 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2026-06-30 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2026-06-30 0001446159us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-30 0001446159us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-30 0001446159us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-30 0001446159us-gaap:FairValueMeasurementsRecurringMember2026-06-30 0001446159agpu:AethirATHMember2025-01-012025-12-31 0001446159agpu:AethirATHMember2025-12-31 0001446159agpu:AethirATHMember2026-01-012026-06-30 0001446159agpu:AethirATHMember2026-06-30 0001446159agpu:AethirATHMemberagpu:SideLetterAgreementMember2025-10-07 0001446159agpu:AethirFoundationMemberagpu:AethirATHMember2026-06-30 0001446159agpu:AethirFoundationMemberagpu:AethirATHMember2026-04-012026-06-30 0001446159agpu:AethirFoundationMemberagpu:AethirATHMember2026-01-012026-06-30 0001446159agpu:NonATHMember2026-06-30 0001446159agpu:AethirATHMember2026-04-012026-06-30 0001446159agpu:AethirATHMember2026-03-31 00014461592029-01-012026-06-30 00014461592028-01-012026-06-30 00014461592027-01-012026-06-30 00014461592026-07-012026-06-30 00014461592025-06-30 00014461592024-12-31 0001446159agpu:DrugDiscoveryServicesMember2025-12-31 0001446159agpu:ComputeServicesMember2026-06-30 0001446159us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerCMember2026-01-012026-06-30 0001446159us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-01-012026-06-30 0001446159us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-01-012026-06-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-01-012026-06-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-04-012026-06-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-01-012026-06-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-04-012026-06-30 0001446159us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberagpu:BirminghamLaboratoryAndEaganBusinessMember2025-01-012025-06-30 0001446159us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberagpu:BirminghamLaboratoryAndEaganBusinessMember2025-04-012025-06-30 0001446159us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberagpu:BirminghamLaboratoryAndEaganBusinessMember2025-06-30 0001446159agpu:EaganBusinessMember2025-03-14 0001446159agpu:LaboratoryEquipmentMembersrt:MaximumMember2026-06-30 0001446159agpu:LaboratoryEquipmentMembersrt:MinimumMember2026-06-30 0001446159us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2026-06-30 0001446159us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2026-06-30 0001446159us-gaap:OfficeEquipmentMembersrt:MaximumMember2026-06-30 0001446159us-gaap:OfficeEquipmentMembersrt:MinimumMember2026-06-30 0001446159us-gaap:TechnologyEquipmentMembersrt:MaximumMember2026-06-30 0001446159us-gaap:TechnologyEquipmentMembersrt:MinimumMember2026-06-30 0001446159agpu:ReverseStockSplitMember2025-09-292025-09-29 0001446159us-gaap:RetainedEarningsMember2025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001446159us-gaap:CommonStockMember2025-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2025-06-30 0001446159us-gaap:RetainedEarningsMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMember2025-04-012025-06-30 0001446159agpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:RetainedEarningsMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159agpu:May2025PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:RetainedEarningsMemberagpu:May2025PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:May2025PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMemberagpu:May2025PrivatePlacementMember2025-04-012025-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMemberagpu:May2025PrivatePlacementMember2025-04-012025-06-30 00014461592025-03-31 0001446159us-gaap:RetainedEarningsMember2025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001446159us-gaap:CommonStockMember2025-03-31 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2025-03-31 00014461592025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001446159agpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159agpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMember2024-12-31 0001446159us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001446159us-gaap:CommonStockMember2024-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2024-12-31 0001446159us-gaap:RetainedEarningsMember2026-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001446159us-gaap:CommonStockMember2026-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001446159us-gaap:RetainedEarningsMember2026-04-012026-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-30 0001446159us-gaap:CommonStockMember2026-04-012026-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2026-04-012026-06-30 0001446159agpu:AtTheMarketOfferingMember2026-04-012026-06-30 0001446159us-gaap:RetainedEarningsMemberagpu:AtTheMarketOfferingMember2026-04-012026-06-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:AtTheMarketOfferingMember2026-04-012026-06-30 0001446159us-gaap:CommonStockMemberagpu:AtTheMarketOfferingMember2026-04-012026-06-30 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMemberagpu:AtTheMarketOfferingMember2026-04-012026-06-30 00014461592026-03-31 0001446159us-gaap:RetainedEarningsMember2026-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001446159us-gaap:CommonStockMember2026-03-31 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2026-03-31 00014461592026-01-012026-03-31 0001446159us-gaap:RetainedEarningsMember2026-01-012026-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31 0001446159us-gaap:CommonStockMember2026-01-012026-03-31 0001446159us-gaap:RetainedEarningsMember2025-12-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001446159us-gaap:CommonStockMember2025-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-06-30 00014461592026-08-13
 
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2026

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________________________ to _________________________

 

Commission File Number: 001-36790

 

 

Axe Compute Inc.

 
 

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

33-1007393

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

     

91 43rd Street, Suite 110 PittsburghPennsylvania

 

15201

(Address of principal executive offices)

 

(Zip Code)

 

(412) 432-1500

(Registrant’s telephone number, including area code)

 

 

N/A

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.01 par value

AGPU

NASDAQ Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes   ☐ No

 

1

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   ☒ No

 

As of August 13, 2026, the registrant had 11,591,124 shares of common stock, par value $0.01 per share outstanding.

 

 

 

 

 

 

 

 

 

 

2

  

 

AXE COMPUTE INC.

 

TABLE OF CONTENTS

 

 

Page

PART I. FINANCIAL INFORMATION

4
   

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

5
   

CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2026 AND DECEMBER 31, 2025

5

   

CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025

6

   

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025

7

   

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025

8

   

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

9

   

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

25

   

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

32
   

ITEM 4. CONTROLS AND PROCEDURES

32
   

PART II. OTHER INFORMATION

32
   

ITEM 1. LEGAL PROCEEDINGS

32
   

ITEM 1A. RISK FACTORS

32
   

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

38
   

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

38
   

ITEM 4. MINE SAFETY DISCLOSURES

38
   

ITEM 5. OTHER INFORMATION

38
   

ITEM 6. EXHIBITS

38
   

SIGNATURES

39

 

3

  

 

PART I. FINANCIAL INFORMATION

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

In addition to historical information, certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"). All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, our results of operations, financial position and our business outlook, business trends and other information, may be forward-looking statements. You can identify these forward-looking statements by the words "believes," "intends," "expects," “might,” "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," “potential,” "predicts," "estimates," "anticipates," “future,” “goal,” and variations of such words or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved, and actual future results may differ materially from what is expressed in or indicated by the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A, under the heading “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 31, 2026, and under “Part II, Item 1A., Risk Factors” in this Quarterly Report on Form 10-Q, if and as such risk factors may be updated from time to time in our periodic filings with the SEC. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and a reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

We caution you that the risks, uncertainties and other factors referenced above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct, or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this Quarterly Report on Form 10-Q apply only as of the date of this Quarterly Report on Form 10-Q or as of the date they were made or as otherwise specified herein. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

 

4

 

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   

June 30,

2026

   

December 31,

2025

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 21,905,767     $ 10,790,850  

Accounts receivable

    3,321,426       32,120  

Compute prepayments

    11,148,981       -  

Other prepaid expense and current assets

    873,423       280,904  

Digital assets

    11,268,342       24,439,598  

Digital asset receivable

    7,547,221       7,226,475  

Total current assets

    56,065,160       42,769,947  
                 

Compute prepayments, net of current portion

    22,946,761       -  

Digital asset receivable, net of current portion

    2,745,004       8,258,681  

Property and equipment, net

    17,291,873       223,128  

Lease right-of-use assets

    1,180,560       1,487,703  

Other long-term assets

    146,598       148,887  

Total assets

  $ 100,375,956     $ 52,888,346  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 2,494,038     $ 1,840,608  

Note payable

    413,611       107,951  

Accrued expenses and other liabilities

    1,425,113       1,520,518  

Contract liabilities

    33,645,987       144,076  

Lease liability

    708,159       653,743  

Total current liabilities

    38,686,908       4,266,896  
                 

Contract liabilities, net of current portion

    27,108,685       -  

Lease liability, net of current portion

    535,168       904,495  

Total liabilities

  $ 66,330,761     $ 5,171,391  

Commitments and contingencies (Note 8)

               
                 

Stockholders’ equity:

               

Preferred stock, 20,000,000 shares authorized inclusive of designated below

               

Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of June 30, 2026 and December 31, 2025

    792       792  

Common stock, $.01 par value, 200,000,000 shares authorized, 11,384,940 and 4,083,173 shares outstanding as of June 30, 2026, and December 31, 2025, respectively

    113,849       40,832  

Additional paid-in capital

    472,366,853       461,196,805  

Accumulated deficit

    (438,436,299 )     (413,521,474 )

Total stockholders’ equity

    34,045,195       47,716,955  
                 

Total liabilities and stockholders’ equity

  $ 100,375,956     $ 52,888,346  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

5

 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS

(Unaudited)

 

    Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $ 3,214,992     $ 2,682     $ 3,250,303     $ 112,992  
                                 

Gains (losses) on digital assets

    (13,125,352 )     -       (17,421,620 )     -  
                                 

Operating costs and expenses:

                               

Cost of revenues

  $ 3,013,339     $ 18,221     $ 3,016,195     $ 63,339  

General and administrative

    2,735,922       1,875,655       5,644,958       3,703,855  

Research and development

    492,227       499,715       1,039,672       1,020,121  

Sales and marketing

    1,176,162       268,959       1,184,549       272,592  

Total operating costs and expenses

    7,417,650       2,662,550       10,885,374       5,059,907  
                                 

Total operating (loss)

  $ (17,328,010 )  

$

(2,659,868 )   $ (25,056,691 )   $ (4,946,915 )
                                 

Other income

    124,220       682,424       144,848       685,852  

Other expense

    (2,092

)

    (1,451 )     (2,982 )     (3,248 )

Loss from continuing operations

    (17,205,882 )     (1,978,896 )     (24,914,825 )     (4,264,311 )

Loss from discontinued operations

    -       (91,567 )     -       (249,024 )

Net (loss)

  $ (17,205,882

)

  $ (2,070,462

)

  $ (24,914,825 )   $ (4,513,335 )
                                 

Loss per common share, basic and diluted:

                               

Loss from continuing operations

  $ (0.87 )   $ (0.22 )   $ (1.45 )   $ (0.52 )

Loss from discontinued operations

    -       (0.01 )     -       (0.03 )

Net (loss) per common share, basic and diluted

  $ (0.87 )   $ (0.23 )   $ (1.45 )   $ (0.55 )
                                 

Weighted average shares used in computation – basic and diluted

    19,685,811       9,108,984       17,167,696       8,136,008  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

6

 
 

 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (DEFICIT)

FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2026 and 2025

(Unaudited)

 

   

Series B Preferred

   

Common Stock

   

Additional Paid-In

   

Accumulated

         
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2025

    79,246     $ 792       4,083,173     $ 40,832     $ 461,196,805     $ (413,521,474 )   $ 47,716,955  

Share-based compensation related to instruments granted to employees

    -       -       -       -       111,358       -       111,358  

Issuance of common stock, net, in connection with restricted stock units vesting

    -       -       13,242       132       (17,576 )     -       (17,444 )

Issuance of shares to non-employees

    -       -       23,613       237       168,597       -       168,833  

Issuance of shares pursuant to pre-funded warrant exercises

    -       -       1,419,239       14,193       (14,192 )     -       1  

Net loss

    -       -       -       -       -       (7,708,943 )     (7,708,943 )

Balance at March 31, 2026

    79,246     $ 792       5,539,267     $ 55,394     $ 461,444,992     $ (421,230,417 )   $ 40,270,761  

Share-based compensation related to instruments granted to employees

    -       -       -       -       571,584       -       571,584  

Issuance of shares pursuant to At The Market Offering, net of issuance costs

    -       -       1,063,864       10,638       10,325,486       -       10,336,124  

Issuance of common stock, net, in connection with restricted stock units vesting

    -       -       26,393       264       (56,941 )     -       (56,677 )

Issuance of shares to non-employees

    -       -       27,984       279       129,006       -       129,285  

Issuance of shares pursuant to pre-funded warrant exercises

    -       -       4,727,432       47,274       (47,274 )     -       -  

Net loss

    -       -       -       -       -       (17,205,882 )     (17,205,882 )

Balance at June 30, 2026

    79,246     $ 792       11,384,940     $ 113,849     $ 472,366,853     $ (438,436,299 )   $ 34,045,195  

 

 

   

Series B Preferred

   

Common Stock

   

Additional Paid-In

   

Accumulated

         
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2024

    79,246     $ 792       444,475     $ 4,445     $ 180,218,424     $ (180,426,271 )   $ (202,610 )

Issuance of shares pursuant to warrant exercises

    -       -       95,601       956       1,533,426       -       1,534,382  

Issuance of shares pursuant to Registered Direct Offering, net of issuance costs

    -       -       24,223       242       465,063       -       465,305  

Issuance of shares pursuant to Renovaro Extension Agreement

    -       -       31,153       312       499,688       -       500,000  

Net loss

    -       -       -       -       -       (2,442,873 )     (2,442,873 )

Balance at March 31, 2025

    79,246     $ 792       595,452     $ 5,955     $ 182,716,601     $ (182,869,144 )   $ (145,796 )

Issuance of shares pursuant to May 2025 private placement

    -       -       18,692       187       299,813       -       300,000  

Issuance of shares pursuant to At The Market Offering, net of issuance costs

    -       -       18,987       190       162,670       -       162,860  

Issuance of shares to non-employees

    -       -       6,667       67       99,933       -       100,000  

Net loss

    -       -       -       -       -       (2,070,462 )     (2,070,462 )

Balance at June 30, 2025

    79,246     $ 792       639,798     $ 6,399     $ 183,279,017     $ (184,939,606 )   $ (1,653,398 )

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

7

 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    Six Months Ended

June 30,

 
    2026    

2025

 

Cash flow from continuing operating activities:

               

Net loss

  $ (24,914,825

)

  $ (4,513,335

)

Less: (loss) from discontinued operations

    -       (249,024 )

Net loss from continuing operations

    (24,914,825 )     (4,264,311 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    54,650       65,222  

Amortization of operating lease right-of-use assets

    307,143       271,099  

Non-cash write off of accounts payable and related accrued expenses

    -       (676,678 )

Share-based compensation

    682,942       -  

Issuance of shares to non-employees

    -       66,667  
Cost of booking compute using digital assets     942,567       -  
Losses on digital assets     17,421,620       -  
                 

Changes in assets and liabilities:

               

Accounts receivable

    (3,289,306 )     11,197  

Inventories

    -       3,054  

Other prepaid expense and other assets

    (592,519 )     (297,818 )

Compute prepayments

    (34,095,742 )     -  

Accounts payable

    653,430       511,791  

Accrued expenses and other liabilities

    (95,406 )     371,361  

Contract liabilities

    60,610,596       (75,000 )

Operating lease liability

    (314,911 )     (267,216 )

Net cash provided by (used in) continuing operating activities:

    17,370,239       (4,280,632 )
                 

Cash flow from continuing investing activities:

               

Purchase of property and equipment

    (17,121,106 )     -  

Net cash (used in) continuing investing activities:

    (17,121,106 )     -  
                 

Cash flow from continuing financing activities:

               

Proceeds from issuance of common stock and warrants

    10,844,932       3,165,365  

Costs to issue common stock and warrants

    (210,687 )     (202,820 )

Payments for taxes related to net share settlement of restricted stock units

    (74,121 )     -  

Proceeds from issuance of financing note payable

    413,611       264,048  

Repayment of note payable

    (107,951 )     -  

Net cash provided by continuing financing activities:

    10,865,784       3,226,593  
                 

Discontinued operations:

               

Net cash provided by operating activities

    -       200,444  

Net cash provided by investing activities

    -       625,000  

Net cash provided by financing activities

    -       -  

Net cash provided by discontinued operations

    -       825,444  
                 

Net increase (decrease) in cash

    11,114,917       (228,595 )

Cash and cash equivalents from continuing operations at beginning of period

    10,790,850       611,822  

Cash and cash equivalents from discontinued operations at beginning of period

    -       122,851  

Less: Cash from discontinued operations at end of period

    -       -  

Cash and cash equivalents from continuing operations at end of period

  $ 21,905,767     $ 506,078  
                 

Supplemental disclosure for cash flow information:

               

Cash payments for interest

  $ 2,982     $ 1,797  
                 

Non-cash transactions:

               
Common stock issued as prepayment for services   $ -     $ 33,333  

Non-cash transfer from prepaid to property and equipment

    (10,500 )     -  

Shares issued for vested RSUs, net of shares withheld for taxes

    396       -  

Realized loss on digital assets

    1,329,854       -  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

8

 

 

AXE COMPUTE INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

NOTE 1 COMPANY INFORMATION

 

Nature of Operations

 

Axe Compute Inc. is a technology company focused on providing high-performance computing infrastructure for artificial intelligence (“AI”) workloads by sourcing large-scale graphics processing unit (“GPU”) capacity from hardware manufacturers and infrastructure suppliers and deploying that capacity for enterprise customers under long-term service agreements. The Company assists customers across the full GPU infrastructure stack, including hardware procurement, colocation, networking, storage, and financing, and can immediately access compute capacity through relationships with third party compute providers to provide customers compute capacity that is already online and available for rent. The Company also continues to evaluate strategic alternatives for its legacy oncology drug discovery business (the “Legacy Business”), including its proprietary biobank of tumor samples and historical drug response data, which is not part of the Company’s core compute infrastructure operations.

 

Compute Services

 

The Company’s principal revenue-generating activity is the provision of GPU compute to customers. The Company primarily provides compute services under two customer models: (1) designing and deploying customized, large scale compute infrastructure solutions for enterprise clients; and (2) providing immediate access to GPU capacity (in as little as 24-48 hours) that is already online and available for rent from third parties.

 

For customers seeking large-scale, long-duration GPU compute capacity, the Company builds and deploys dedicated compute infrastructure solutions. Under this model, customers contract for dedicated AI infrastructure tailored to their compute, performance, geographic, security, and operational requirements. The Company coordinates with customers to architect deployments that may include GPU compute, high-speed storage, networking, power infrastructure, and related managed services. Deployments are typically hosted in enterprise-grade data center facilities and are operated by the Company pursuant to service level commitments. The Company intends to finance and then retain ownership of the deployed hardware and related infrastructure, while providing customers access to the infrastructure through multi-year service agreements. Customer contracts are typically structured with deposits, prepayments, and recurring monthly payments, including take-or-pay provisions intended to provide income visibility throughout the contract term.

 

For customers that need immediate access to GPU compute capacity, the Company provides access to high-performance GPU compute infrastructure. Our access to third-party networks encompasses global locations and GPUs capable of supporting a broad range of artificial intelligence, machine learning, and high-performance computing workloads. Compute capacity is delivered to customers through a managed infrastructure model, typically within 48 hours of customer engagement, without requiring customers to make capital investments in physical hardware or data center facilities.

 

Drug Discovery Services / Legacy Business

 

The provision of compute services is the priority of the Company and remains its focus. The Company also maintains its legacy oncology drug discovery solutions business, which was previously conducted under the Predictive Oncology Inc. name. Current operations in this business are limited, and the Company is exploring strategic alternatives, including a potential sale or other disposition, although no definitive plan has been approved. Historically, this business applied AI to support the discovery and development of cancer therapies, with the objective of improving treatment effectiveness and patient outcomes. The business leveraged AI capabilities to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. In February 2026, the Company announced that it is exploring strategic alternatives for this oncology drug discovery solutions business. However, as of the date of this Quarterly Report on Form 10-Q, the Company’s Board of Directors has not yet committed to a specific course of action.

 

9

 

For further discussion of the Company’s operating segments as of and for the six months ended June 30, 2026, see Note 14 Segment Information.

 

Strategic Compute Reserve

 

On September 29, 2025, the Company adopted a treasury strategy centered on ATH, the native utility token of the Aethir network. Aethir is a decentralized physical infrastructure network developed by DCI Foundation, a Panama foundation company ("DCI"), that aggregates enterprise-grade GPU resources to support artificial intelligence, cloud gaming and other compute-intensive workloads. ATH functions as a proxy for a unit of GPU compute power and serves as the medium of exchange and incentive mechanism for participants in the Aethir network.

 

Under this strategy, the Company maintains a Strategic Compute Reserve comprised primarily of ATH, which provides the Company with immediate access to GPU compute capacity that can be deployed to customers. As a holder of ATH, the Company accrues unrealized gains or losses from any appreciation or depreciation, as applicable, in the value of ATH tokens, which trade on various cryptocurrency exchanges.

 

The Company seeks to generate value from its ATH holdings principally by utilizing ATH to procure GPU compute capacity on the Aethir network and reselling that capacity to enterprise, research and commercial customers. The Company has not engaged in ATH staking to date and does not currently intend to stake ATH, although it may elect to do so in the future.

 

The Company's Strategic Compute Reserve is intended to create value for stockholders through:

 

 

Maintaining access to GPU compute capacity through ownership of ATH;

 

 

Deploying ATH to acquire compute capacity and reselling that capacity to customers;

 

 

Opportunistically purchasing ATH in the open market, including receiving additional ATH incentives under the DCI agreement;

 

 

Earning yield through lending arrangements and other approved treasury activities;

 

 

Holding ATH as a strategic reserve to support future compute demand; and

 

 

Selling ATH from time to time to support working capital requirements, operational needs or other corporate purposes.

 

Refer to "Risks and Uncertainties" below for further discussion regarding risks related to the Company's Strategic Compute Reserve.

 

Liquidity

 

Since the adoption of the Company’s treasury strategy based on ATH, the Company has raised capital through private investment in public equity (“PIPE”) transactions and at-the-market (“ATM”) sales of shares of common stock. Additional details regarding these equity offerings are included in Note 11 Stockholders Equity. These capital raises have strengthened the Company’s liquidity position, and the $21.9 million of cash and cash equivalents remaining as of June 30, 2026, together with $11.3 million of digital assets, represent readily accessible sources of liquidity. The Company believes its sources of liquidity will be sufficient to allow the Company to fund its planned operations for at least the next twelve months from the date of this Quarterly Report on Form 10-Q.

 

Reverse Stock Split

 

On September 19, 2025, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation, as amended, to effect a one-for-fifteen reverse stock split of the Company’s common stock. On September 29, 2025, the Company completed a one-for-fifteen reverse stock split that was effective for trading purposes on September 30, 2025 (the “Reverse Stock Split”). All numbers of shares and per-share amounts in this report have been adjusted to reflect the Reverse Stock Split.

 

10

 

As a result of the Reverse Stock Split, every 15 shares of issued and outstanding common stock were combined into one issued and outstanding share of common stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split and any fractional shares that would otherwise have resulted from the Reverse Stock Split were rounded up to the nearest whole share. The Reverse Stock Split did not change the total number of authorized shares of common stock or preferred stock.

 

 

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The Company has prepared the condensed consolidated financial statements and related unaudited financial information in the notes in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim condensed consolidated financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim condensed consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which in the opinion of management, are necessary to present fairly the Company’s position, the results of its operations, and its cash flows for the interim periods. These interim condensed consolidated financial statements reflect all intercompany eliminations. These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026.

 

As of and for the six months ended June 30, 2026, and 2025, the Company had two wholly owned subsidiaries, Helomics Corporation and Skyline Medical Inc. (“Skyline Medical”). On March 14, 2025, the Company sold the Skyline Medical business pursuant to an asset purchase agreement with DeRoyal Industries, Inc.; however, Skyline Medical remained a wholly owned subsidiary of Axe Compute following the transaction, with its activities limited to wind-down efforts that were substantially completed as of December 31, 2025. The condensed consolidated financial statements include the accounts of the Company and these wholly owned subsidiaries, with all intercompany transactions and balances eliminated, as of and for the six months ended June 30, 2026 and 2025.

 

Discontinued Operations

 

In March 2025, the Company disposed of its former Eagan operating segment. Disposal groups that meet the discontinued operations criteria provided in ASC 205-20-45 are classified as discontinued operations. Assets and liabilities of discontinued operations are presented separately in the Company’s condensed consolidated balance sheets and results of discontinued operations are reported as a separate component of net loss in the Company’s condensed consolidated statements of net loss for all periods presented, resulting in changes to the presentation of certain prior period amounts. Results of discontinued operations are excluded from segment results for all periods presented. Cash flows from discontinued operations are also reported separately in the Company’s condensed consolidated statements of cash flows.

 

Refer to Note 3 Discontinued Operations for additional discussion of discontinued operations. All other notes to these condensed consolidated financial statements present the results of continuing operations and exclude amounts related to discontinued operations for all periods presented.

 

Accounting Policies and Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and during the reporting period. Actual results could materially differ from those estimates. Estimates are used in the following areas, among others: variable consideration associated with revenue recognition, stock-based compensation expense, fair value of derivatives including embedded derivatives, fair value of digital assets, fair value of long-lived assets for impairment analyses, the valuation allowance included in the deferred income tax calculation, accrued expenses, useful lives assigned to property and equipment, and determination of contract commencement dates. The Company bases its estimates on historical experience and assumptions that management considers reasonable. Assumptions are reviewed regularly to ensure they remain relevant and reasonable, particularly in areas of high subjectivity.

 

11

 

Note 2 to the annual consolidated financial statements contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026, describes the significant accounting policies and estimates used in preparation of the consolidated financial statements. There have been no material changes in the Company’s significant accounting policies during the six months ended June 30, 2026, with the exception of the items noted below.

 

Revenues from GPU Compute Services

 

Revenue from the Company’s GPU compute services segment is generated from subscription-based arrangements with enterprise, research, and commercial customers under master services agreements and related order forms. These arrangements provide customers with continuous access to specified GPU compute resources (including GPU type, quantity, and configuration) at designated data center locations over defined service periods, which may range from month-to-month to multi-year terms. Certain contracts also include ancillary storage services, which are accounted for as separate performance obligations when distinct.

 

The Company procures GPU compute capacity from third-party node operators and decentralized cloud infrastructure platforms and resells that capacity to its customers. The Company has concluded that it acts as a principal in these arrangements, as it controls the GPU compute services prior to transferring to the customer, including directing the use of, and obtaining substantially all benefits from, the underlying capacity. Additionally, the Company bears inventory risk and has full discretion regarding the pricing of contracts with customers. Accordingly, revenue is recognized on a gross basis.

 

GPU compute and related storage services are each considered a series of distinct services that are substantially the same and are satisfied over time, as customers simultaneously receive and consume the benefits of these services as they are provided. Revenue is recognized over time using an output method that faithfully depicts the Company’s performance. For fixed-fee arrangements, revenue is recognized on a straight-line basis over the applicable service period, as the customer receives a consistent level of benefit throughout the term. Usage-based fees, including overage charges based on GPU-hours consumed in excess of contractual limits, are recognized as revenue in the period in which the usage occurs.

 

The transaction price primarily consists of fixed monthly subscription fees, which are generally non-cancellable and non-refundable during the contract term. Arrangements might include usage-based overages; however, for the period ended June 30, 2026, any variable consideration was immaterial. Variable consideration is included in revenue only to the extent it is probable that a significant reversal will not occur. For contracts with multiple performance obligations, such as combined GPU compute and storage services, the transaction price is allocated to performance obligations based on relative standalone selling prices. The Company has concluded that these arrangements do not contain significant financing components.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation. Construction-in-progress is related to the construction or development of property and equipment that has not yet been placed into service for its intended use. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets.

 

The estimated useful lives of the Company’s property and equipment are as follows:

 

 

Years

Technology equipment

5

-

7

Computers, software, and office equipment

3

-

10

Leasehold improvements (1)

1

-

2

Laboratory equipment

4

-

10

 

(1)

Leasehold improvements are amortized over the shorter of the useful life or the remaining lease term.

 

Upon retirement or sale of property and equipment, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recorded in operations. Expenditures for maintenance and repairs that do not extend the lives of the respective assets are expensed as incurred.

 

Compute prepayments

 

The Company enters into agreements with third-party vendors to reserve and obtain GPU compute capacity, related storage, networking, and support services. Under these arrangements, the Company is generally required to make prepayments equal to either (1) a percentage of overall contract value or (2) a value equal to the monthly service payment for a number of months. In addition to these prepayments, the Company has monthly service payments over contract terms ranging from 12 to 36 months.

 

Upon transferring these prepayments, the Company records a compute prepayment as a prepaid asset. The prepaid balance is subsequently recognized as expense over the period in which the related services are received. For arrangements where the prepayment represents an advance payment for services evenly consumed over the contract term, the prepaid balance is amortized on a straight-line basis over the applicable service period. For arrangements where the prepayment relates to specific months of service, the prepaid balance is relieved and recognized as expense in the months to which the prepayment applies, consistent with the pattern of benefit received. Monthly service payments are recognized as expense as incurred in accordance with the underlying contractual terms. The Company evaluates compute prepayments each reporting period to determine whether the recorded balance remains recoverable and appropriately reflects expected future service consumption.

 

The timing of service deployment and commencement under certain compute capacity arrangements is dependent on a variety of third-party factors, including original equipment manufacturer (“OEM”) schedules, GPU allocation timing, logistics, and other operational dependencies. As a result, at the time a compute prepayment is made, the exact period over which the prepaid balance will be utilized may not be known with certainty. Management is therefore required to estimate the expected service commencement date and the period over which the related services will be received in order to determine the appropriate classification of compute prepayments between current and non-current assets and to establish the amortization period. These estimates are based on the facts and circumstances known at the reporting date and are reassessed each reporting period. Changes in actual deployment timing or service consumption patterns may result in adjustments to the classification and timing of expense recognition in future periods.

 

Risks and Uncertainties

 

Note 2 to the annual consolidated financial statements contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026, describes certain risks and uncertainties associated with the Company and relevant to the Company’s consolidated financial statements. There have been no additional risks and uncertainties identified by Management in the six months ended June 30, 2026.

 

Recently Issued Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

 

12

 

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires more detailed disclosures related to certain costs and expenses. The guidance requires entities to disclose amounts of certain expense categories included in expense captions presented on the face of the income statement, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization. This ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The disclosure requirements may be applied either prospectively or retrospectively. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.

 

 

NOTE 3 DISCONTINUED OPERATIONS

 

On March 14, 2025, the Company entered into an asset purchase agreement (the “APA”) and closed the transactions contemplated therein with DeRoyal Industries, Inc., a Tennessee corporation (“DeRoyal”), to sell and assign to DeRoyal assets and liabilities exclusively related to the business of providing products for automated, direct-to-drain medical fluid disposal, including the Company’s STREAMWAY® product line (the “Eagan Business”). These assets were operated by the Company’s wholly owned subsidiary, Skyline Medical, and were previously reported in the Company’s Eagan operating segment. The purchased assets exclusively related to the Eagan Business included but were not limited to cash, certain accounts receivable, inventories, patents, fixed assets, and real property leased by the Company and exclusively used in connection with the Eagan Business. The total purchase price for the assets was $625,000, plus the assumption of certain liabilities related to the Eagan Business including the lease for the office and warehouse space located at 2915 Commers Drive Suite 900 Eagan, MN 55121, certain accounts payable, and contract liabilities associated with the Eagan Business. The ongoing activities of the former Eagan operating segment are limited to wind down activities. As a result of these developments, the former Eagan operating segments have been reclassified to discontinued operations in these condensed consolidated financial statements for all periods presented.

 

The balance sheet as of June 30, 2026, does not include any assets and liabilities of discontinued operations. The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities to the current assets and liabilities of discontinued operations as presented in the Company’s condensed consolidated balance sheet as of June 30, 2025:

 

   

June 30,

2025

 

Assets:

       

Accounts receivable, net

  $ 37,297  

Prepaid expense and other assets

    10,426  

Total current assets of discontinued operations

    47,723  
         

Other long-term assets

    4,031  

Total assets of discontinued operations

  $ 51,754  
         

Liabilities:

       

Accounts payable

  $ 1,149  

Accrued expenses and other liabilities

    252,015  

Lease liability

    89,040  

Total current liabilities of discontinued operations

    342,204  
         

Total liabilities

  $ 342,204  

 

13

 

The statement of net loss as of June 30, 2026, does not include any discontinued operation activity. The following table provides details about the major classes of line items constituting the loss from discontinued operations presented in the Company’s condensed consolidated statement of net loss for the three and six months ended June 30, 2025:

 

    For the three months ended

June 30, 2025

   

For the six months ended

June 30, 2025

 

Revenue

 

$

-     $ 157,179  

Cost of sales

    -       122,800  

Gross profit from discontinued operations

    -       34,379  
                 

Operating expenses:

               

General and administrative

    101,103       204,341  

Research and development

    2,669       125,495  

Sales and marketing

    -       130,318  

Total operating expenses

    103,772       460,154  

Total operating (loss) from discontinued operations

    (103,772 )     (425,775 )

Gain on disposal of discontinued operations

    -       172,451  

Other (expense)

    12,205       4,300  

Net (loss) from discontinued operations

 

$

(91,567 )   $ (249,024 )

 

The gain on disposal of discontinued operations represents the gain on assets sold and liabilities assumed by DeRoyal.

 

 

NOTE 4 REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

 

Disaggregation of Revenue

 

The Company primarily generates its revenue through providing GPU compute services for fixed term contracts. Revenue recognized related to fixed term contracts represented substantially all of the revenue for the three and six months ended June 30, 2026.

 

Contracts with Customers

 

The following customers accounted for 10% or more of the Company’s revenue for the periods presented:

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Customer A

    49 %     *       49 %     *  

Customer B

    27 %     *       27 %     *  

Customer C

    *       *       *       *  

 

* Customer did not represent 10% or more of revenue.

 

Customer A, B, and C accounted for 16%, 13%, and 58% of accounts receivable, net, respectively, as of June 30, 2026. All other single customers represent less than 10% of revenue and accounts receivable, net, for the three and six month periods ended and as of June 30, 2026.

 

The Company monitors the creditworthiness of its customers on an ongoing basis and believes that its credit risk is limited due to the financial strength and payment history of these customers. Management does not expect any material losses from these receivable concentrations and has not recorded an allowance for doubtful accounts, as all receivables are considered highly collectible.

 

Contract Balances

 

The Company’s contract balances are comprised of prepayments received from compute services customers. The Company invoices for services in advance and when the Company receives consideration (or has an unconditional right to consideration) before services are fulfilled, the Company recognizes a contract liability for the unfulfilled performance obligation. These prepayments are classified as contract liabilities until the appropriate revenue recognition criteria have been met.  As of June 30, 2026, the Company had contract liabilities of $60.7 million primarily related to compute services. As of December 31, 2025, the Company had contract liabilities of $0.1 million which was all related to Drug Discovery Services.

 

14

 

The following table represents a reconciliation of the changes in the Company’s contract balances:

 

   

June 30, 2026

   

June 30, 2025

 

Balance, beginning of period

  $ 144,076     $ 224,076  

Advance billings

    63,822,941       -  

Revenue recognized

    (3,212,345 )     (75,000 )

Balance, end of period

  $ 60,754,672     $ 149,076  

 

During the six months ended June 30, 2026, an immaterial amount of revenue was recognized relating to the contract liabilities as of December 31, 2025.

 

The Company had no contract assets as of the periods presented, as the Company’s right to consideration becomes unconditional upon invoicing (which occurs at or before the service period commences) and does not depend on any factor other than passage of time.

 

As of June 30, 2026, the Company had $60.8 million of remaining performance obligations. The Company expects to recognize revenue associated with these performance obligations as follows:

 

2026 (remaining 6 months)

  $ 29,301,246  

2027

    7,053,109  

2028

    1,906,741  

2029

    22,493,576  
    $ 60,754,672  

  

 

NOTE 5 DIGITAL ASSETS

 

The Company’s digital assets, as presented on the condensed consolidated balance sheets for the periods indicated, consist primarily of ATH. ATH qualifies for recurring fair-value measurement under ASC 350-60, Intangibles — Goodwill and Other — Accounting for and Disclosure of Crypto Assets, with changes in fair value recognized in earnings in accordance with ASC 820, Fair Value Measurement, based on quoted (unadjusted) prices on the principal market of the Company for ATH (Level 1 inputs). The following table summarizes the number of units held, cost basis, and fair value of ATH as of June 30, 2026 and December 31, 2025:

 

   

Units Held

   

Cost Basis

   

Fair Value

 

June 30, 2026

    2,655,414,499     $ 94,739,253     $ 11,144,775  

December 31, 2025

    2,837,163,868     $ 101,258,178     $ 24,439,334  

 

Cost basis represents the purchase price of digital assets, including transaction fees, if any, at the time of acquisition or upon receipt. Fair value represents quoted prices for the digital assets in the Company’s principal market at 11:59 p.m. Eastern Time on each reporting date in accordance with the Company’s crypto-asset valuation policy.

 

The following table represents a reconciliation of digital assets held, for ATH specific activity:

 

   

For the Six Months Ended
June 30, 2026

 

Fair Value, December 31, 2025

  $ 24,439,334  
         
Purchases of ATH     -  

ATH used in operations

    (1,143,222 )

Interest income from ATH loaned

    76,896  
Realized (loss)     (1,329,854 )

Unrealized (loss)

    (10,898,379 )

Fair Value, June 30, 2026

  $ 11,144,775  

 

15

 

   

For the Three Months Ended
June 30, 2026

 

Fair Value, March 31, 2026

  $ 20,233,245  
         
Purchases of ATH     -  

ATH used in operations

    (1,111,134 )

Interest income from ATH loaned

    76,896  
Realized (loss)     (1,329,854 )

Unrealized (loss)

    (6,724,378 )

Fair Value, June 30, 2026

  $ 11,144,775  

 

As of June 30, 2026, the Company held $0.1 million of non-ATH digital assets.

 

ATH tokens were utilized primarily for the rental of GPU compute capacity on the Aethir decentralized infrastructure network, supporting the Company's compute-related operations.

 

During the six months ended June 30, 2026, the Company generated ATH-denominated digital asset lending income through a digital asset lending arrangement. The Company transferred 2.4 billion ATH tokens via the Aethir portal for a defined period of time of 31 calendar days. The lending arrangement accrued interest at a fixed annual rate of 6%, calculated on a simple interest basis. Upon expiration of the term of the digital asset lending arrangement, the principal amount and accrued interest were repaid in full. For the six months ended June 30, 2026, the Company recognized digital asset lending income of $0.1 million. As of June 30, 2026, no digital assets held by the Company were subject to the lending arrangement.

 

Side Letter

 

In connection with private placement transactions completed in October 2025 to support the Company’s treasury strategy, the Company entered into a side letter agreement (the “Side Letter”) with DCI, effective October 7, 2025. Pursuant to the Side Letter, for each ATH token purchased by the Company in the open market, whether through centralized or decentralized exchanges operating on the Ethereum Network, DCI will grant the Company additional ATH tokens equal to 20% of the number of tokens purchased (the “Bonus ATH”), to be delivered within 30 days of the related purchase. The Bonus ATH is not subject to restrictions upon receipt.

 

The Company accounts for the Side Letter as a derivative instrument. As of June 30, 2026 and December 31, 2025, respectively, no derivative asset was recognized, as all Bonus ATH associated with open market purchases made during the period had been received from DCI.

 

For the six months ended June 30, 2026, the Company did not receive any Bonus ATH as there were no open market purchases of ATH made during the period. The cost basis of the ATH received in prior periods pursuant to the Side Letter and subsequent fair value adjustments thereto are recorded within “Gains (losses) on digital assets” on the condensed consolidated statements of net loss.

 

Digital asset receivable

 

A portion of the Company’s ATH holdings consists of contractual rights to receive ATH tokens that are subject to time-based vesting and transfer restrictions (“Locked ATH”). Locked ATH was obtained pursuant to Simple Agreements for Future Tokens (“SAFTs”) and is administered through an on-chain smart contract deployed on the Ethereum mainnet. Prior to vesting and claim, the Company does not have control of the underlying ATH tokens and is not able to transfer, sell, stake, pledge, or otherwise deploy such tokens.

 

The smart contract enforces the applicable vesting schedules and restricts access to the ATH tokens until the vesting conditions are satisfied. Upon satisfaction of the vesting conditions, the Company must affirmatively claim the unlocked ATH tokens through the smart contract interface, at which point the tokens are released from restriction and transferred to a Company-controlled wallet. Until such claim occurs, the Locked ATH represents a contractual right to receive ATH in the future rather than a digital asset held by the Company.

 

16

 

As of June 30, 2026, the Company held rights to receive ATH tokens that remain subject to vesting and claim requirements. The vesting period for these ATH tokens ranges from less than one month to approximately 3 years. These restrictions are specific to the underlying ATH tokens. Upon vesting and claim, the restrictions lapse and the Company obtains control of the ATH tokens, which may then be held, transferred to custodial accounts, staked, or otherwise deployed in accordance with the Company’s treasury strategy.

 

As of June 30, 2026, the Company recorded a digital asset receivable of $10.3 million related to the Locked ATH, consisting of a host receivable of $93.4 million, net of an embedded derivative liability measured at fair value of $83.1 million. The change in fair value of the embedded derivative of $5.2 million for the six months ended June 30, 2026, was recognized within “Gains (losses) on digital assets” in the condensed consolidated statements of net loss.

 

As of December 31, 2025, the Company recorded a digital asset receivable of $15.5 million related to the Locked ATH, consisting of a host receivable of $93.4 million, net of an embedded derivative liability measured at fair value of $77.9 million. The change in fair value of the embedded derivative of $77.9 million for the year ended December 31, 2025, was recognized within “Gains (losses) on digital assets” in the condensed consolidated statements of net loss.

 

 

NOTE 6 FAIR VALUE MEASUREMENTS

 

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value as of June 30, 2026 and December 31, 2025, respectively. Fair value estimates do not necessarily represent the amounts that may be ultimately realized.

 

June 30, 2026

 

Fair Value

   

Level 1

   

Level 2

   

Level 3

 

Assets:

                               

Cash equivalents

  $ 20,000,000     $ 20,000,000     $ -     $ -  

Digital assets

    11,268,342       11,268,342       -       -  

Embedded derivative related to digital asset receivable

  $ (83,086,868 )   $ -     $ -     $ (83,086,868 )

 

December 31, 2025

 

Fair Value

   

Level 1

   

Level 2

   

Level 3

 

Assets:

                               

Digital assets

  $ 24,439,598     $ 24,439,598     $ -     $ -  

Embedded derivative related to digital asset receivable

  $ (77,893,482 )   $ -     $ -     $ (77,893,482 )

 

Cash equivalents represent the Company’s money market investments. The fair value of these investments is based on the daily market price for identical assets in active markets.

 

The embedded derivative related to the digital asset receivable must be remeasured at fair value each reporting period in accordance with ASC 815, Derivatives and Hedging. Because there is no directly observable market for illiquid, contractually restricted ATH tokens subject to a time-based vesting schedule, the embedded derivative related to digital asset receivable is classified as Level 3. The key unobservable input is the discount applied to reflect the lack of transferability and control during the restriction period. The discount is determined based on the remaining vesting period from each reporting period to the date on which the tokens become fully vested and available to claim, and is reduced ratably at each subsequent measurement date until it reaches zero at full vesting. As of the six months ended June 30, 2026, applied discounts ranged from approximately 20% to 45%. As of December 31, 2025, applied discounts ranged from approximately 30% to 55%. Changes in fair value of the embedded derivative are recognized in the consolidated statements of net loss within "Gains (losses) on digital assets." There were no transfers into or out of Level 3 of the fair value hierarchy during the six months ended June 30, 2026, or the year ended December 31, 2025.

 

17

  

 

NOTE 7 PROPERTY AND EQUIPMENT, NET

 

The Company’s property and equipment, net consisted of the following:

 

   

As of

June 30,

2026

   

As of

December 31,

2025

 

Computers, software, and office equipment

 

$

170,350    

$

170,350  

Construction in progress - Technology equipment

    17,100,106       -  

Leasehold improvements

    166,847       166,847  

Laboratory equipment

    1,713,230       1,692,230  

Total

    19,150,533       2,029,427  

Less: Accumulated depreciation

    (1,858,660 )     (1,806,299 )

Total Property and equipment, net

  $ 17,291,873     $ 223,128  

 

Depreciation expense, recorded within general and administrative expenses of continuing operations, was $25,089 and $31,467 for the three months ended June 30, 2026 and 2025, respectively, and $52,361 and $62,934 for the six months ended June 30, 2026 and 2025, respectively.

 

During the three months ended June 30, 2026, the Company purchased $17.1 million of technology equipment related to the infrastructure solutions model within the compute services business. As of June 30, 2026, the entirety of the technology equipment balance represents construction in progress.

 

No impairment charges related to property and equipment held and used in continuing operations were incurred during the three and six months ended June 30, 2026 and 2025.

 

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Commitments

 

During the three months ended June 30, 2026, the Company entered into several agreements with third-party vendors to reserve and obtain access to GPU compute capacity, related storage, networking, and support services. Management has evaluated these arrangements and concluded that they are service commitments and not leases. Under these arrangements, the Company is generally required to make upfront payments and, following service commencement or operational activation, monthly service payments over contract terms ranging from 12 to 36 months. These arrangements represent total contractual commitments to be paid according to the following schedule:

 

2026 (remaining 6 months)

  $ 16,757,954  

2027

    107,744,100  

2028

    99,220,630  

2029

    38,852,831  

Total

  $ 262,575,515  

 

Litigation

 

In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. In accordance with ASC 450, Contingencies (“ASC 450”), the Company accrues a liability for legal contingencies when it is probable that a liability has been incurred, and the amount of the loss can be reasonably estimated. If there is at least a reasonable possibility that a loss may be incurred, ASC 450 requires disclosure of a loss contingency.

 

There have been no material changes to the Company’s contingencies as disclosed in the Form 10-K for the year ended December 31, 2025.

 

 

NOTE 9 LEASES

 

The Company’s corporate offices and other offices are located in Pittsburgh, Pennsylvania. The leases are effective through February 29, 2028.

 

Lease expense under operating lease arrangements, recorded within general and administrative expenses of continuing operations, was $196,169 for the three months ended June 30, 2026 and 2025, and $392,337and $392,503 for the six months ended June 30, 2026 and 2025, respectively.

 

The following table summarizes the operating lease asset and liabilities recorded as of June 30, 2026 and December 31, 2025:

 

    June 30,

2026

   

December 31,

2025

 

Operating lease right-of-use asset, gross

  $ 2,922,365     $ 2,922,365  

Accumulated amortization

    (1,741,805 )     (1,434,662 )

Operating lease right-of-use asset, net

    1,180,560       1,487,703  
                 

Short-term operating lease liabilities

    708,159       653,743  

Long-term operating lease liabilities

    535,168       904,495  

Total operating lease liabilities

  $ 1,243,327     $ 1,558,238  
                 

Weighted average remaining lease term – operating leases in years

    1.67       2.16  

Weighted average discount rate – operating leases

    12.5 %     13.0 %

 

18

 

The Company’s operating lease obligations as of June 30, 2026, which include expected lease extensions that are reasonably certain of renewal, were as follows:

 

2026 (remaining 6 months)

  $ 403,618  

2027

    827,909  

2028

    139,022  

Total lease payments

    1,370,549  

Less: interest

    (127,222

)

Present value of lease liabilities

  $ 1,243,327  

  

 

NOTE 10 NOTE PAYABLE

 

In June 2026, the Company purchased director and officer insurance policies with a policy period ending June 2027 and financed $0.4 million of its total premium by entering into a note payable with a finance provider that requires ten monthly installment payments through April 2027. The note is secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.1% over the life of the note. As of June 30, 2026, the outstanding balance of the note was $0.4 million including interest.

 

In June 2025, the Company purchased director and officer insurance policies with a policy period ending June 2026 and financed $0.3 million of its total premium by entering into a note payable with a finance provider that required ten monthly installment payments through April 2026. The note was secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.6% over the life of the note. As of December 31, 2025, the outstanding balance of the note was $0.1 million including interest.

 

 

NOTE 11 STOCKHOLDERS EQUITY

 

At The Market Offering

 

On May 3, 2024, the Company entered into an at-the-market (“ATM”) sales agreement with Wainwright & Co., LLC (“Wainwright”), under which it may issue and sell shares of its common stock, with Wainwright acting as sales agent and receiving a 3.0% commission on gross proceeds. The Company subsequently filed a shelf registration statement and prospectus supplement.

 

On April 18, 2025, in accordance with the terms of the Sales Agreement, the Company filed a prospectus supplement to the May 2024 Shelf Registration Statement relating to the offer and sale of up to an additional $1.5 million of shares of the Company’s common stock.

 

On June 2, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $1.4 million remaining as of May 31, 2025, up to an aggregate of $3.4 million, and the Company filed an additional prospectus supplement with the SEC on June 2, 2025.

 

On October 29, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $2.3 million remaining as of September 30, 2025, up to an aggregate of $18.3 million, and the Company filed an additional prospectus supplement with the SEC on October 29, 2025.

 

During April 2026, the company sold 1,063,864 shares of common stock pursuant to the Sales Agreement at an average price of approximately $10.22 per share, resulting in approximately $10.3 million in aggregate net proceeds, after deducting commissions and offering costs.

 

On May 15, 2026, in accordance with the terms of the Sales Agreement, the Company filed an additional prospectus supplement with the SEC increasing the aggregate amount of common stock that may be offered and sold under the Sales Agreement to up to $100 million, inclusive of approximately $17.0 million of shares previously sold under the Sales Agreement, resulting in approximately $83.0 million remaining available to the Company for future sales thereunder. Since the Company's public float exceeded $75.0 million as of May 15, 2026, the Company is no longer subject to the baby shelf limitations of General Instruction I.B.6 of Form S-3.

 

19

 

As of June 30, 2026, approximately $83.0 million remained available to the Company for sales under the Sales Agreement.

 

September 2025 Private Placements and Related Agreements

 

On September 29, 2025, the Company entered into a securities purchase agreement (the “Crypto SPA”) with certain accredited investors pursuant to which the Company agreed to sell and issue to such investors in a private placement (the “Crypto PIPE Offering”) pre-funded warrants (the “Crypto PIPE Warrants”). Also on September 29, 2025, the Company entered into a securities purchase agreement (the “Cash SPA,” and together with the Crypto SPA, the “September SPAs”), pursuant to which it agreed to sell and issue to certain accredited investors, in exchange for cash (the “Cash PIPE Offering,” and together with the Crypto PIPE Offering, the “PIPE Offerings”), the Company’s common stock and warrants (the “Cash PIPE Warrants”). The PIPE Offerings closed October 7, 2025 (the “Closing Date”).

 

Cash PIPE and Crypto PIPE

 

In the Cash PIPE Offering, the Company sold an aggregate of 4,366,703 shares of common stock (or pre-funded warrants at a nominal $0.01 exercise price per share to purchase shares of common stock, in lieu thereof) to certain accredited investors for $11.6265 per share. In the Crypto PIPE, the Company issued, to certain accredited investors, Crypto PIPE Warrants to purchase up to 14,903,393 shares of its common stock at a nominal $0.01 exercise price per share.

 

There were 6,146,671 pre-funded warrants exercised for the six months ended June 30, 2026, and the total number of pre-funded warrants outstanding was 9,972,424 as of June 30, 2026, all of which were vested and exercisable and have no expiration date.

 

Stock Warrants

 

The following summarizes transactions for warrants for the period indicated: 

 

   

Number of
Shares

   

Weighted-Average
Exercise
Price

 

Outstanding as of December 31, 2025

    1,623,179     $ 17.39  

Issued

    -          

Expired

    -          

Exercised

    (6,136 )     219.09  

Outstanding as of June 30, 2026

    1,617,043     $ 16.62  

 

There were no warrants granted for the six months ended June 30, 2026 and 2025, respectively.

 

 

NOTE 12 STOCK-BASED COMPENSATION

 

Equity Incentive Plan

 

On December 30, 2024, the Company’s stockholders approved the 2024 Equity Incentive Plan (the “2024 Plan”). The 2024 Plan allows for the issuance of non-statutory stock options and incentive stock options, stock appreciation rights, stock awards, restricted stock, restricted stock units, and performance awards to employees, directors, and consultants of the Company, where permitted under the plan. Due to the approval of the 2024 Plan, no new awards will be granted under the Company’s Amended and Restated 2012 Stock Incentive Plan. The exercise price for each stock option is determined by the market price on the date of issuance. Vesting requirements are determined by the Board of Directors when granted and currently range from immediate to three years. Options outstanding under this plan have a contractual life of ten years.

 

ASC 718, Compensation Stock Compensation (“ASC 718”), requires that a company that issues equity as compensation record compensation expense that corresponds to the estimated cost of those equity grants. ASC 718 requires companies to estimate the fair value of stock-based payment awards on the date of grant using an option-pricing model or other acceptable means.

 

Restricted Stock Units

 

On September 9, 2025, the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors (the “Compensation Committee”), determined that it was appropriate to award restricted stock units (“RSUs”) as a form of compensation for employees, consultants and directors and approved a form of Restricted Stock Unit Award Agreement, with such awards to be granted under the Company’s 2024 Plan. Consistent with that determination, the Board of Directors approved the grant of 60,101 RSUs on September 9, 2025. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs contained a service-based vesting condition requiring continued service through October 31, 2025, at which point the RSUs vested in full. The RSUs were settled on November 28, 2025.

 

On December 10, 2025, the Company entered into an amendment to the employment agreement with Raymond F. Vennare dated as of November 1, 2022. Pursuant to the amendment and following approval by the Compensation Committee, Mr. Vennare was awarded 20,000 RSUs. The RSUs contained a service-based vesting condition requiring continued service through January 1, 2026, at which point the RSUs vested in full. The RSUs were settled on February 5, 2026.

 

20

 

During the six months ended June 30, 2026, 33,330 additional RSUs were granted to employees and consultants under the Company’s 2024 Plan. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs vested in full upon the RSU grant date.

 

The following table summarizes the Company’s RSU activity for the period indicated: 

 

   

Number of
Shares

   

Weighted-Average Grant Date Fair Value per RSU

 

Non-vested RSUs as of December 31, 2025

    20,000     $ 5.92  

Granted

    33,330     $ 5.84  

Vested

    (53,330 )   $ 5.86  

Non-vested RSUs as of June 30, 2026

    -          

 

The Company has no unrecognized stock-based compensation expense related to RSUs that is expected to be recognized in a future period.

 

Stock Options

 

The Company determines the grant date fair value of options and warrants using a Black-Scholes option valuation model based upon assumptions regarding risk-free interest rate, expected dividend rate, volatility, and estimated term. There were 1,025,000 stock options granted for the six months ended June 30, 2026. There were no stock options granted for the six months ended June 30, 2025.

 

The following table summarizes the Company’s stock option activity for the period indicated:

 

    Number of
Shares
   

Weighted-Average
Exercise
Price

    Weighted-Average Remaining Contractual Term (Years)    

Aggregate Intrinsic value

 

Outstanding as of December 31, 2025

    2,925     $ 1,334.98       2.99       -  

Issued

    1,025,000     $ 1.09       9.67     $ 5,372,100  

Expired

    (7 )   $ 12,107.14       -       -  

Exercised

    -       -       -       -  

Outstanding as of June 30, 2026

    1,027,918     $ 6.05       9.65     $ 5,372,100  

 

The fair value of each option grant for the six months ended June 30, 2026 and 2025, was estimated on the grant date using the Black-Scholes option valuation model with the following assumptions:

 

    Six Months Ended June 30,  
   

2026

   

2025

 

Expected dividend yield

    0.0 %     0.0 %

Expected stock price volatility

    99.4% - 103.5 %     99.4 %

Risk-free interest rate

    4.22% - 4.33 %     4.37 %

Expected life (in years)

 

10

   

5

 

 

The Company has $1.9 million of unrecognized stock-based compensation expense related to stock options that is expected to be recognized over the next approximately three years.

 

Stock-Based Compensation Expense, Net

 

Stock-based compensation expense, net of forfeitures, recognized for the three and six months ended June 30, 2026, was $0.6 million and $0.7 million, respectively. There was no stock-based compensation expense recognized for the three and six months ended June 30, 2025. Such expense is included within general and administrative expenses in the condensed consolidated statements of net loss.

 

21

  

 

NOTE 13 NET LOSS PER SHARE

 

Earnings per share accounting requires the presentation of both basic and diluted earnings per share on the face of the statements of net loss. The Company calculates basic net loss per share based upon the weighted average number of common shares outstanding during the period, while the calculation of diluted earnings per share includes the dilutive effect of potential common shares outstanding during the period. The calculation of diluted earnings per share excludes all potential common shares, with the exception of pre-funded warrants, if their inclusion would have an anti-dilutive effect. A total of 9,972,424 pre-funded warrants is included in the computation of earnings per share because the exercise price of the pre-funded warrants is nominal and there are no conditions that must be satisfied prior to their exercise.

 

The following table presents the shares used in the basic and diluted loss per common share computations:

 

    Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Numerator:

                               

Net (loss) from continuing operations

  $ (17,205,882 )   $ (1,978,896 )   $ (24,914,825 )   $ (4,264,311 )

Net (loss) from discontinued operations

    -       (91,567 )     -       (249,024 )

Net (loss) attributable to common stockholders

    (17,205,882 )     (2,070,462 )     (24,914,825 )     (4,513,335 )
                                 

Denominator:

                               

Weighted average common shares outstanding - basic

    19,685,811       9,108,984       17,167,696       8,136,008  

Dilutive effect of stock options, warrants and preferred stock (1)

    -       -       -       -  

Weighted average common shares outstanding - diluted

    19,685,811       9,108,984       17,167,696       8,136,008  
                                 

Net (loss) from continuing operations attributable to common stockholders per common share – basic and diluted

    (0.87 )     (0.22 )     (1.45 )     (0.52 )

Net (loss) from discontinued operations attributable to common stockholders per common share – basic and diluted

    -       (0.01 )     -       (0.03 )

(Loss) per common share - basic and diluted

    (0.87 )     (0.23 )     (1.45 )     (0.55 )

 

 

(1)

The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive:

 

    Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Options

    1,027,918       42,113       1,027,918       42,113  

Warrants

    1,617,043       940,412       1,617,043       940,412  

Restricted stock units

    -       -       -       -  

Preferred stock: Series B

    2       2       2       2  

  

 

NOTE 14 SEGMENT INFORMATION

 

The Company has determined its operating segments in accordance with ASC 280, Segment Reporting. Factors used to determine the Company’s reportable segments include the availability of separate financial statements, the existence of separate leadership across business lines, the economic factors affecting each segment, and the evaluation of operating results at the segment level. The Company’s Chief Operating Decision Maker (“CODM”), its chief executive officer, allocates the Company’s resources for each of the operating segments and evaluates their relative performance based on losses from operations, operating loss, and net loss. Operating expenses are disaggregated by department for purposes of evaluating each segment’s performance. Each operating segment listed below has separate financial statements and locally based leadership that are evaluated based on the results of their respective segments. It should be noted that the operating segments below have different products and services.

 

22

 

The Company has two reportable segments, which have been delineated by business area:

 

 

Compute Services and Treasury Management segment: provides services that include access to GPU compute capacity and manages the Company’s ATH treasury strategy.

 

 

Drug Discovery Services segment: provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development.

 

As described in Note 3 Discontinued Operations, the Company’s former Eagan operating segment met the criteria to be reported as discontinued operations for the first quarter of 2025. As such, the former Eagan operating segment is excluded from the tables below, which only reflect continuing operations for all periods presented.

 

See discussion of revenue recognition in Note 2 Summary of Significant Accounting Policies for a description of the products and services recognized in each segment. All revenues are earned from external customers.

 

The table below summarizes the Company’s segment reporting as of the six months ended June 30, 2026, and the year ended December 31, 2025:

 

Compute Services and Treasury Management segment  

June 30,

2026

   

December 31,

2025

 

Assets

  $ 96,017,868     $ 49,455,174  

Depreciation and amortization

    -       -  

Expenditures for additions to long-lived assets

    (17,100,106 )     -  
                 

Drug Discovery Services segment

               

Assets

  $ 1,634,178     $ 1,930,898  

Depreciation and amortization

    51,425       121,261  

Expenditures for additions to long-lived assets

    (21,000 )     -  
                 

Corporate

               

Assets

  $ 2,723,910     $ 1,502,274  

Depreciation and amortization

    3,225       7,777  

Expenditures for additions to long-lived assets

    -       -  
                 

Total

               

Assets

  $ 100,375,956     $ 52,888,346  

Depreciation and amortization

    54,650       129,038  

Expenditures for additions to long-lived assets

    (17,121,106 )     -  

 

23

 

The table below provides a reconciliation of segment revenue and loss for the three and six months ended June 30, 2026 and 2025:

 

   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Compute Services and Treasury Management segment

                               

Revenue

  $ 3,207,345     $ -     $ 3,214,280     $ -  

Gains and (losses) from operations

    (13,125,352 )     -       (17,421,620 )     -  

Cost of operations (a)

    4,098,199       -       4,289,848       -  

Total operating (loss)

    (14,016,206 )     -       (18,497,187 )     -  

Segment (loss)

    (14,016,206 )     -       (18,497,187 )     -  
                                 

Drug Discovery Services segment

                               

Revenue

    7,647       2,682       36,023       112,992  

Gains and (losses) from operations

    -       -       -       -  

Cost of operations (a)

    930,704       899,077       1,944,940       1,876,810  

Total operating (loss)

    (923,057 )     (896,395 )     (1,908,917 )     (1,763,818 )

Segment (loss)

    (923,057 )     (896,395 )     (1,908,917 )     (1,763,818 )
                                 

Corporate

                               

Revenue

    -       -       -       -  

Gains and (losses) from operations

    -       -       -       -  

Cost of operations (a) (b)

    2,388,747       1,763,473       4,650,586       3,183,097  

Total operating (loss)

    (2,388,747 )     (1,763,473 )     (4,650,586 )     (3,183,097 )

Segment (loss)

    (2,388,747 )     (1,763,473 )     (4,650,586 )     (3,183,097 )
                                 

Total

                               

Revenue

    3,214,992       2,682       3,250,303       112,992  

Gains and (losses) from operations

    (13,125,352 )     -       (17,421,620 )     -  

Cost of operations (a)

    7,417,650       2,662,550       10,885,374       5,059,907  

Total operating (loss)

    (17,328,010 )     (2,659,868 )     (25,056,691 )     (4,946,915 )

Other segment items

    122,128       589,406       141,866       433,580  

Net (loss)

    (17,205,882 )     (2,070,462 )     (24,914,825 )     (4,513,335 )

 

 

(a)

Segment cost of operations includes cost of revenues, general and administrative expenses, research and development expenses, and sales and marketing expenses.

 

 

(b)

Corporate expenses include general and administrative costs, stock-based compensation, and other items not allocated to the segments.

 

 

NOTE 15 SUBSEQUENT EVENTS

 

Significant Contracts

 

In July 2026, the Company secured three new customer contracts with a total contract value of more than $2.8 billion across the United States and Europe. The agreements, secured through the Axe Compute Build program, expand Axe Compute’s design-deploy-own-operate model into additional geographies and add significant dedicated, large-scale AI infrastructure capacity to its global footprint.

 

 

 

 

 

24

 

  

 

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, and our Form 10-K for the year ended December 31, 2025.

 

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"). All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, our results of operations, financial position and our business outlook, business trends and other information, may be forward-looking statements. You can identify these forward-looking statements by the words "believes," "intends," "expects," “might,” "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," “potential,” "predicts," "estimates," "anticipates," “future,” “goal,” and variations of such words or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved, and actual future results may differ materially from what is expressed in or indicated by the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A, under the heading “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on March 31, 2026, and under “Part II, Item 1A., Risk Factors” in this Quarterly Report on Form 10-Q, if and as such risk factors may be updated from time to time in our periodic filings with the SEC. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and a reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

Overview

 

Axe Compute Inc. is a technology company focused on providing high-performance computing infrastructure for artificial intelligence (“AI”) workloads by sourcing large-scale graphics processing unit (“GPU”) capacity from hardware manufacturers and infrastructure suppliers and deploying that capacity for enterprise customers under long-term service agreements. We assist customers across the full GPU infrastructure stack, including hardware procurement, colocation, networking, storage, and financing. We can also immediately access compute capacity through relationships with third party compute providers to provide customers compute capacity that is already online and available for rent. We also continue to evaluate strategic alternatives for our legacy oncology drug discovery business (the “Legacy Business”), including its proprietary biobank of tumor samples and historical drug response data, which is not part of our core compute infrastructure operations.

 

Compute Services

 

Our principal revenue-generating activity is the provision of GPU compute to customers. We primarily provide compute services under two customer models: (1) designing and deploying customized, large scale compute infrastructure solutions for enterprise clients; and (2) providing immediate access to GPU capacity (in as fast as 24-48 hours) that is already online and available for rent from third parties.

 

For customers seeking large-scale, long-duration GPU compute capacity, we build and deploy dedicated compute infrastructure solutions. Under this model, customers contract for dedicated AI infrastructure tailored to their compute, performance, geographic, security, and operational requirements. We coordinate with customers to architect deployments that may include GPU compute, high-speed storage, networking, power infrastructure, and related managed services. Deployments are typically hosted in enterprise-grade data center facilities and are operated by us pursuant to service level commitments. We  intend to finance and then retain ownership of the deployed hardware and related infrastructure, while providing customers access to the infrastructure through multi-year service agreements. Customer contracts are typically structured with deposits, prepayments, and recurring monthly payments, including take-or-pay provisions intended to provide income visibility throughout the contract term.

 

25

 

For customers that need immediate access to GPU compute capacity, we provide access to high-performance GPU compute infrastructure. Our access to third-party networks encompasses global locations and GPUs capable of supporting a broad range of artificial intelligence, machine learning, and high-performance computing workloads. Compute capacity is delivered to customers through a managed infrastructure model, typically within 48 hours of customer engagement, without requiring customers to make capital investments in physical hardware or data center facilities.

 

Drug Discovery Services / Legacy Business

 

The provision of compute services is our priority and remains our focus. We also maintain our legacy oncology drug discovery solutions business, which was previously conducted under the Predictive Oncology Inc. name. Current operations in this business are limited, and we are exploring strategic alternatives, including a potential sale or other disposition, although no definitive plan has been approved. Historically, this business applied AI to support the discovery and development of cancer therapies, with the objective of improving treatment effectiveness and patient outcomes. The business leveraged AI capabilities to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. In February 2026, we announced that we are exploring strategic alternatives for this oncology drug discovery solutions business. However, as of the date of this Quarterly Report on Form 10-Q, our Board of Directors has not yet committed to a specific course of action.

 

Strategic Compute Reserve

 

On September 29, 2025, we adopted a treasury strategy centered on ATH, the native utility token of the Aethir network. Aethir is a decentralized physical infrastructure network developed by DCI Foundation, a Panama foundation company ("DCI"), that aggregates enterprise-grade GPU resources to support artificial intelligence, cloud gaming and other compute-intensive workloads. ATH functions as a proxy for a unit of GPU compute power and serves as the medium of exchange and incentive mechanism for participants in the Aethir network.

 

Under this strategy, we maintain a Strategic Compute Reserve comprised primarily of ATH, which provides us with immediate access to GPU compute capacity that can be deployed to customers. As a holder of ATH, we accrue unrealized gains or losses from any appreciation or depreciation, as applicable, in the value of ATH tokens, which trade on various cryptocurrency exchanges.

 

We seek to generate value from our ATH holdings principally by utilizing ATH to procure GPU compute capacity on the Aethir network and reselling that capacity to enterprise, research, and commercial customers. We have not engaged in ATH staking to date and do not currently intend to stake ATH, although we may elect to do so in the future.

 

Our Strategic Compute Reserve is intended to create value for stockholders through:

 

 

Maintaining access to GPU compute capacity through ownership of ATH;

 

 

Deploying ATH to acquire compute capacity and reselling that capacity to customers;

 

 

Opportunistically purchasing ATH in the open market, including receiving additional ATH incentives under the DCI agreement;

 

 

Earning yield through lending arrangements and other approved treasury activities;

 

 

Holding ATH as a strategic reserve to support future compute demand; and

 

 

Selling ATH from time to time to support working capital requirements, operational needs or other corporate purposes.

 

There can be no assurance that the value of ATH will increase, and investors should carefully consider the risks associated with digital assets.

 

26

 

Recent Developments

 

During the quarter ended June 30, 2026, we appointed Kyle Okamoto as President effective April 1, 2026, and appointed Jeremy Yaukey-Witter as Chief Financial Officer effective May 18, 2026.

 

On April 22, 2026, we announced our entry into a 36-month enterprise infrastructure contract with an enterprise customer (the “April Agreement”). The April Agreement has an aggregate contract value of approximately $260 million. Under the April Agreement, we will deliver a dedicated cluster of 2,304 NVIDIA B300 GPUs and AI-focused high-speed storage infrastructure from a single U.S. Tier 3 data center facility. The cluster is intended to support large-scale AI model training, fine-tuning, and high-throughput inference workloads. The infrastructure will maintain NVIDIA reference architecture throughout the contract period. The initial term of the Agreement is 36 months, with targeted deployment commencing in the third quarter of 2026. The Agreement includes options to renew for additional years beyond the initial term. 

 

In connection with the April Agreement, we purchased technology equipment of $17.1 million in the quarter ended June 30, 2026. This technology equipment consists of GPU cluster infrastructure and is considered construction in progress as of June 30, 2026, and will begin depreciating when placed in service. 

 

On May 15, 2026, in accordance with the terms of the ATM Sales Agreement with Wainwright, we determined to further increase the number of shares we may sell under the Sales Agreement up to an aggregate of $100.0 million, inclusive of approximately $17.0 million of shares previously sold under the Sales Agreement, and we filed an additional prospectus supplement with the SEC on May 15, 2026. The net proceeds from the shares offered and sold pursuant to the ATM Sales Agreement during the three months ended June 30, 2026, after deduction of commissions and offering expenses, were approximately $10.3 million. As of June 30, 2026, approximately $83.0 million remained available for sales under the Sales Agreement.

 

In July 2026, we secured three new customer contracts with a total contract value of more than $2.8 billion across the United States and Europe. The agreements, secured through the Axe Compute Build program, expand our design-deploy-own-operate model into additional geographies and add significant dedicated, large-scale AI infrastructure capacity to our global footprint.

 

Capital Requirements

 

Since inception, we have incurred recurring losses and have not generated sufficient revenues to fund our operations. Historically, we have financed our activities through a combination of debt and equity financings. Since 2023, we have monetized certain assets and reduced operating expenses. In September 2025, we adopted the aforementioned treasury strategy, which introduced both new sources of capital and additional capital requirements. See “Liquidity and Capital Resources—Liquidity and Plan of Financing” and “Liquidity and Capital Resources—Financing Transactions” below.

 

As of June 30, 2026, we have approximately $21.9 million in cash and cash equivalents. Additionally, we also hold significant ATH digital assets, which may serve as an additional source of liquidity. However, the market price of ATH has exhibited significant volatility over recent periods and remains subject to rapid fluctuations driven by factors such as market sentiment, regulatory developments, network adoption, governance decisions of the Aethir Foundation, and broader crypto-asset market conditions.

 

Additional sources of liquidity include our at-the-market (“ATM”) facility, under which approximately $83.0 million remains available as of the prospectus supplement filed with the SEC on May 15, 2026, as well as a standby equity purchase agreement (“SEPA”) that allows us to sell up to $10.0 million of its common stock, in each case subject to the terms, conditions, and limitations of the respective arrangements.

 

Our future cash requirements and the adequacy of our available resources will depend on our ability to generate revenue from our compute services and treasury strategy, as well as our ability to access additional financing. We expect operating losses to continue in the near term as we scale these initiatives. Given our recent strategic shift, our future operating results are inherently uncertain, and period-to-period comparisons may not be indicative of future performance

 

Results of Operations

 

Comparison of the three months ended June 30, 2026 and 2025:

 

   

2026

   

2025

   

Difference

 

Revenue

  $ 3,214,992     $ 2,682     $ 3,212,310  

Gains (losses) on digital assets

    (13,125,352 )     -       (13,125,352 )

Cost of revenues

    3,013,339       18,221       2,995,118  

General and administrative expenses

    2,735,922       1,875,655       860,267  

Research and development

    492,227       499,715       (7,488 )

Sales and marketing expenses

    1,176,162       268,959       907,203  

Total operating gain (loss)

    (17,328,010 )     (2,659,868 )     (14,668,142 )

Other income (expense)

    122,128       680,973       (558,845 )

Income (loss) from continuing operations

    (17,205,882 )     (1,978,896 )     (15,226,986 )

Income (loss) from discontinued operations

    -       (91,567 )     91,567  

Net income (loss)

  $ (17,205,882 )   $ (2,070,462 )   $ (15,135,420 )

 

27

 

Comparison of the six months ended June 30, 2026 and 2025

 

   

2026

   

2025

   

Difference

 

Revenue

  $ 3,250,303     $ 112,992     $ 3,137,311  

Gains (losses) on digital assets

    (17,421,620 )     -       (17,421,620 )

Cost of revenues

    3,016,195       63,339       2,952,856  

General and administrative expenses

    5,644,958       3,703,855       1,941,103  

Research and development

    1,039,672       1,020,121       19,551  

Sales and marketing expenses

    1,184,549       272,592       911,957  

Total operating gain (loss)

    (25,056,691 )     (4,946,915 )     (20,109,776 )

Other income (expense)

    141,866       682,604       (540,738 )

Income (loss) from continuing operations

    (24,914,825 )     (4,264,311 )     (20,650,514 )

Income (loss) from discontinued operations

    -       (249,024 )     249,024  

Net income (loss)

  $ (24,914,825 )   $ (4,513,335 )   $ (20,401,490 )

 

Revenue. We recognized revenue of $3.3 million for the six months ended June 30, 2026, compared to $0.1 million for the six months ended June 30, 2025. The increase was driven by a shift in our operating activities: revenue in the current period was generated primarily by our Compute Services and Treasury Management segment, while revenue in the prior-year period was attributable to our Drug Discovery Services segment.

 

Gains (losses) on digital assets. We recorded a loss on digital assets of $17.4 million in the six months ended June 30, 2026, with no such losses recorded in the comparative period. The losses in the 2026 period primarily represent the change in fair value of the Company’s ATH holdings, which were not present in the comparative period.

 

Cost of revenues. Cost of revenues was $3.0 million and $0.1 million in the six months ended June 30, 2026 and 2025, respectively. Similarly to revenue, cost of revenues increased due to a shift in our operating activities.

 

General and administrative expenses. General and administrative (“G&A”) expenses primarily consist of management salaries, professional fees, consulting fees, administrative fees, and general office expenses. G&A expenses increased by $1.9 million to $5.6 million in the six months ended June 30, 2026, compared to $3.7 million in the comparable period in 2025. The increase was primarily due to severance expense related to the prior Chief Executive Officer, higher payroll expenses resulting from salary increases for existing employees, hiring of additional employees related to the Compute Services and Treasury Management segment, and increased stock-based compensation expense recognized during the six months ended June 30, 2026.

 

Research and development expenses. Research and development expenses primarily consist of expenses related to product development, prototyping, and testing. Research and development expenses were stable at $1 million in the six months ended June 30, 2026, and 2025.

 

Sales and marketing expenses. Sales and marketing expenses consist of expenses required to market and sell our products and services. Sales and marketing expenses increased by $0.9 million to $1.2 million in the six months ended June 30, 2026, compared to $0.3 million in the comparable period in 2025. The increase was primarily due to increased sales and marketing activities to support the expansion of our compute services business.

 

28

 

Other income. We recognized other income of $0.1 million during the six months ended June 30, 2026, compared to $0.7 million in the comparable period in 2025. Other income in 2026 consisted of income from the Aethir lending arrangement and other income in 2025 consisted of the write-off of aged accounts payable and related accrued expenses.

 

Liquidity and Capital Resources

 

Cash Flows

 

On June 30, 2026, we had $21.9 million in cash and cash equivalents. Cash and cash equivalents from continuing operations increased by $11.1 million from December 31, 2025, due to the following factors.

 

Net cash provided by operating activities of continuing operations was $17.3 million in the six months ended June 30, 2026, compared to net cash used in operating activities of continuing operations of $4.3 million in the six months ended June 30, 2025. The cash provided by operating activities in the 2026 period was driven primarily by a $60.6 million increase in contract liabilities reflecting customer prepayments for compute capacity, partially offset by $34.1 million of compute prepayments and a $3.3 million increase in accounts receivable. Our net loss for the period included non-cash losses on digital assets of $17.4 million, which did not affect operating cash flows.

 

We used cash of $17.1 million in investing activities of continuing operations in the six months ended June 30, 2026, to acquire property and equipment. No cash was used in investing activities of continuing operations in the six months ended June 30, 2025.

 

Net cash provided by financing activities of continuing operations was $10.9 million in the six months ended June 30, 2026, compared to $3.2 million provided by financing activities of continuing operations in the six months ended June 30, 2025. Cash provided by financing activities of continuing operations in the 2026 period was primarily related to net proceeds of $10.8 million from the issuance of common stock and warrants, including sales under our at-the-market offering program. Cash provided by financing activities of continuing operations in the 2025 period was primarily related to proceeds from the issuance of common stock and warrants.

 

No cash was used or provided by discontinued operations in the six months ended June 30, 2026, compared to $0.8 million provided by discontinued operations in the six months ended June 30, 2025. The cash provided in the 2025 period related to proceeds from the sale of Eagan assets pursuant to the asset purchase agreement executed with DeRoyal in March 2025

 

Liquidity and Plan of Financing

 

Liquidity is a measure of our ability to access sufficient cash flows to meet the short-term and long-term cash requirements of our business operations. We have incurred significant and recurring losses from operations for the past several years. As of June 30, 2026, and December 31, 2025, we had cash and cash equivalents of $21.9 million and $10.8 million, respectively, and working capital of $17.4 million and $38.5 million, respectively, and accumulated deficit of $438.4 million and $413.5 million, respectively.

 

To meet our short-term liquidity needs in the next twelve months, which are primarily comprised of working capital requirements, we have access to various sources of short-term liquidity including cash and cash equivalents and ATH tokens in our treasury. These include approximately 2.7 billion ATH tokens as of June 30, 2026, and an additional 1.6 billion ATH tokens expected to vest over the subsequent twelve-month period. Although we do not anticipate needing to use our ATH to meet our short-term liquidity needs, to the extent necessary, we may seek to use proceeds from the sale of our ATH to meet such needs. Additional sources of liquidity could include our ATM facility and the SEPA facility, subject to certain limitations and conditions associated with the respective facilities.

 

29

 

We consider the ATM facility to be a viable source of incremental liquidity during fiscal year 2026, subject to market conditions. We do not assume immediate or full utilization of the ATM facility in our base-case liquidity forecast. Rather, ATM proceeds are considered a discretionary funding source that could be accessed opportunistically during periods of sufficient market liquidity and pricing stability. Based on current market conditions, we believe that any ATM issuances, if undertaken, would likely have potential to occur in fiscal year 2026.

 

Additionally, subsequent to June 30, 2026, the SEC declared effective our Form S-3 registration statement on July 20, 2026. The registration statement permits us to offer up to $1 billion of securities from time to time. No securities have been issued under the registration statement as of June 30, 2026; however, this registration statement allows for future financing flexibility.

 

Beyond the next twelve months, our long-term liquidity needs are primarily for obligations related to working capital requirements. Our ability to meet these needs and the adequacy of available funds depend on our ability to generate income from our compute services and treasury strategy, and the availability of future financing to fulfill our business plans. We will also have access to an additional 1.6 billion ATH tokens expected to be vested beyond twelve months from June 30, 2026.

 

We note that a significant portion of our liquidity is held in ATH, a digital asset, which has exhibited substantial price volatility over recent trailing 3-, 6-, and 9-month periods. We acknowledge that ATH prices are subject to rapid fluctuations due to factors including market sentiment, regulatory developments, network adoption, governance decisions of the Aethir Foundation, and broader crypto-asset market conditions.

 

We have considered downside price scenarios in which the market price of ATH declines materially over the 12-month period following the balance sheet date. Under these scenarios, the U.S. dollar value of our ATH holdings available for liquidity purposes would be reduced, which has the potential to pressure our ability to fund operating expenses.

 

We have incorporated these possible scenarios when determining the our liquidity, however, we believe we have access to sufficient alternative liquidity sources, as noted above, to weather adverse ATH market price conditions

 

Financing Transactions 

 

We have primarily funded our operations through a combination of debt and equity instruments including short-term borrowings, and a variety of debt and equity offerings. We have no off-balance sheet transactions.

 

30

 

At The Market Offering

 

We maintain an ATM equity offering program pursuant to a Sales Agreement with Wainwright under which we may offer and sell shares of our common stock from time to time. In May 2026, we increased the capacity under the ATM program to an aggregate of $100.0 million. During the three months ended June 30, 2026, we received approximately $10.3 million of net proceeds from sales under the ATM program with the most recent bringdown occurring on April 27, 2026. As of June 30, 2026, approximately $83.0 million remained available for future issuances under the program.

 

Standby Equity Purchase Agreement

 

In July 2025, we entered into a Standby Equity Purchase Agreement (“SEPA”) with YA II PN, Ltd. that provides us with the ability to sell up to $10.0 million of common stock from time to time, subject to the terms, conditions and limitations set forth in the agreement. The facility may provide an additional source of capital to support our operations and growth initiatives. As of June 30, 2026, we have not issued any shares or received any proceeds under the SEPA.

 

September 2025 Private Placements

 

In September 2025, we completed private placement transactions consisting of a cash PIPE financing that generated gross proceeds of approximately $50.8 million and a crypto-denominated PIPE transaction for ATH digital assets with a discounted value of approximately $173.3 million. The transactions provided significant capital to support our operational, strategic, and treasury initiatives.

 

Recent Accounting Developments

 

See “Recent Accounting Pronouncements” and “Recently Adopted Accounting Standards” under Note 2 - Summary of Significant Accounting Policies to the unaudited condensed financial statements of this Quarterly Report on Form 10-Q for further details.

 

31

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), defines the term “disclosure controls and procedures” as those controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as of June 30, 2026. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of June 30, 2026.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended June 30, 2026, the Company implemented new processes, controls, and procedures related to revenue recognition related to compute services and its digital asset and compute operations. These changes included enhancements to the Company’s policies, people, technologies, and operational processes designed to address the risks associated with digital asset activities as well as preventative and mitigating controls over the acquisition, custody, safeguarding, valuation, and financial reporting of digital assets.

 

As the Company continues to expand its digital asset and compute operations, management continues to enhance and refine certain processes and controls related to wallet management, custody arrangements, valuation methodologies, and related financial reporting activities in order to support the Company’s evolving operations and reporting requirements. Other than the changes described herein, there were no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) during the quarter ended June 30, 2026, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

In the ordinary course of business, we may periodically become subject to legal proceedings and claims arising in connection with ongoing business activities from time to time. The results of litigation and claims cannot be predicted with certainty, and unfavorable resolutions are possible and could materially affect our results of operations, cash flows or financial position. In addition, regardless of the outcome, litigation could have an adverse impact on us because of defense costs, diversion of management attention and resources and other factors. 

 

Information regarding our legal proceedings can be found in Note 8, Contingencies, to the unaudited condensed consolidated financial statements of this Quarterly Report on Form 10-Q.

 

ITEM 1A. RISK FACTORS

 

Except as set forth below, there have been no material changes to our risk factors from those disclosed under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 31, 2026 (the “2025 Form 10-K”). On June 9, 2026, we filed a Current Report on Form 8-K furnishing supplemental risk factors that reflect our expansion into the purchase, ownership, and operation of GPU computing infrastructure deployed in data center facilities. The risk factors set forth below supplement and update the risk factors disclosed in the 2025 Form 10-K and should be read together with the risk factors and other information contained in the 2025 Form 10-K and our other filings with the SEC. To the extent the following is inconsistent with the risk factors in the 2025 Form 10-K, the following supersedes those risk factors. Any of the following risks could materially and adversely affect our business, financial condition, results of operations, and prospects, and the trading price of our common stock could decline. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also impair our business operations

 

32

 

Risks Related to Our Ownership and Operation of GPU Computing Infrastructure

 

Our expansion into owning and operating GPU computing infrastructure is capital-intensive and will require substantial and growing capital expenditures, and any inability to obtain capital on acceptable terms may adversely affect our business.

 

We have historically pursued an asset-light operating model under which we did not own GPU computing hardware within physical data center facilities and instead provided access to GPU compute capacity primarily through infrastructure made available by the Aethir network. We have now expanded our business to purchase, own, and operate GPU computing hardware. This owned-asset model is substantially more capital-intensive than our prior model and will require significant and growing capital expenditures to procure, deploy, maintain, upgrade, and expand our infrastructure. We expect to fund these expenditures through a combination of customer deposits and prepayments, cash from operations, and equity and debt financing, which may not be available to us on favorable terms, or at all. If adequate financing is not available when required, we may be unable to acquire the hardware and infrastructure necessary to fulfill our customer commitments or execute our growth strategy. If we raise additional funds through equity or convertible securities, our existing stockholders may experience substantial dilution, and any such securities may have rights, preferences, and privileges senior to those of our common stock.

 

The GPUs and related infrastructure we will now own are subject to rapid technological obsolescence, and our results of operations depend on our ability to accurately estimate their useful lives and to avoid impairment of these assets.

 

Unlike our prior model, in which we did not own the underlying compute hardware, we now bear the full economic risk of the GPUs and related equipment we purchase. GPU technology is advancing rapidly, and newer generations of GPUs that offer materially better performance, efficiency, or total cost of ownership are introduced frequently. As a result, the GPUs and related infrastructure we will now own may become obsolete, decline in value, or generate lower pricing and utilization than we anticipate before the end of their expected useful lives. We must make estimates regarding the useful lives of our computing equipment and our ability to redeploy that equipment beyond the term of any initial customer contract, and we cannot guarantee that these estimates will prove accurate. If our assumptions regarding useful lives, residual values, redeployment, or utilization prove incorrect, or if events or changes in circumstances indicate that the carrying amount of our infrastructure may not be recoverable, we may be required to accelerate depreciation or record material impairment charges, which could materially and adversely affect our reported financial results.

 

A substantial portion of our compute revenue is expected to be derived from a limited number of customers and contracts, and the loss of, or non-performance by, any such customer would adversely affect our business.

 

We expect that, for the foreseeable future, a substantial portion of our compute revenue will be concentrated among a small number of customers and contracts. This concentration exposes us to heightened counterparty credit risk and to the risk of non-payment or non-performance, including in the event a customer experiences financial difficulty, insolvency, or bankruptcy. Although our contract is structured on a take-or-pay basis and secured with a deposit, prepayment, and monthly in-advance payments, we cannot assure you that a customer will perform its obligations, that the definitive agreement will be enforceable in accordance with its terms, or that a customer will exercise any renewal option. The loss of, a default by, a dispute with, or a significant reduction in spending by any one of our major customers, or our inability to replace such revenue on comparable terms, could have a disproportionate adverse effect on our business, results of operations, and financial condition.

 

Our compute business depends on the operation of dedicated data center facilities, including the availability of reliable power and cooling, and operational failures at these facilities could materially disrupt our ability to serve customers.

 

Our expanded business depends on deploying and operating owned GPU infrastructure within dedicated data center facilities. The performance, availability, and delivery of our services depend on numerous factors, many of which are outside our control, including the continued availability and functioning of power and cooling systems, the success or failure of redundancy, disaster recovery, and business continuity systems, and decisions or failures by the third-party owners and operators of the facilities in which our infrastructure is installed. Such data centers and associated infrastructure are also subject to risks of damage, interruption, or destruction from power outages, equipment failures, fires, floods, natural disasters, physical or cybersecurity attacks, human error, and other events. Because the deployment under our largest contract to date is concentrated in a single facility, any prolonged outage, capacity constraint, or other disruption affecting that facility could prevent us from meeting contracted service levels, expose us to service credits, penalties, or termination rights, and materially and adversely affect our business.

 

 

 

33

 

Our business could be harmed if we are unable to secure sufficient power, or by increases in the cost of power or the imposition of new regulatory requirements on data center power consumption.

 

Operating owned GPU infrastructure requires access to substantial, reliable, and cost-effective electrical power; our largest deployment to date requires 4.8 megawatts of committed power capacity alone. The rapid expansion of AI and large-scale data center development has significantly increased electricity demand in certain markets, and policymakers, utilities, and regulators are increasingly scrutinizing the impact of data centers on ratepayers, grid reliability, and the environment. We may face power outages, shortages, capacity constraints, interconnection delays, or significant increases in the cost of securing power, any of which could limit our ability to operate or expand our infrastructure. In addition, governments may impose new requirements on data center operators, including obligations to fund grid upgrades, procure dedicated generation, enter into long-term capacity arrangements, accept curtailment during periods of grid stress, or satisfy additional permitting, carbon reporting, or cost-allocation requirements, and may restrict, condition, or delay new data center development. The global energy market has experienced significant volatility and inflationary pressure, and we expect power costs to remain volatile and unpredictable. Any of these developments could increase our operating costs, impair our ability to serve customers, delay our growth, and materially and adversely affect our business.

 

We depend on a limited number of suppliers, and primarily on NVIDIA, for the GPUs and other hardware we purchase, and any supply disruption, delay, or price increase could impair our ability to deploy infrastructure and fulfill customer commitments.

 

Our ability to acquire and deploy owned GPU infrastructure depends on our ability to procure GPUs and related hardware in sufficient quantities, on acceptable terms, and within timeframes consistent with our customer commitments. We source GPU hardware primarily from NVIDIA, which is currently the dominant supplier of GPUs used for AI training and inference, and we do not manufacture any hardware ourselves. Reliance on a limited number of suppliers exposes us to a range of risks, including limited availability of the latest-generation components, lack of control over production costs, delivery, and pricing, extended or unpredictable lead times, the potential for binding price or purchase commitments at above-market rates, supplier prioritization of other customers, and shifts in market-leading technologies away from those offered by our current suppliers. Our suppliers in turn rely on complex networks of third-party suppliers, including semiconductor foundries such as Taiwan Semiconductor Manufacturing Company, and any disruption affecting these upstream suppliers, whether due to geopolitical factors, capacity constraints, or natural disasters, could affect the availability and cost of the hardware we require. The loss of or significant disruption to our access to NVIDIA GPU supply and related hardware, or material price increases or extended delivery lead times, could delay our deployments, including our targeted third-quarter 2026 deployment, reduce our available capacity, and materially and adversely affect our business.

 

We may be unable to deploy our owned infrastructure on the timelines we have committed, and delays in deployment could result in penalties, lost revenue, or reputational harm.

 

Our largest contract to date contemplates a dedicated cluster purpose-built to the customer's specifications, with a targeted deployment start in the third quarter of 2026. The procurement, integration, configuration, and commissioning of large-scale GPU clusters and associated storage, networking, power, and cooling infrastructure is complex and subject to numerous potential points of failure, including hardware delivery delays, facility readiness, the availability of data center equipment such as switchgear, power distribution units, and cooling equipment, the availability of skilled labor, and dependence on third-party facility operators and contractors. Our forward-looking statements regarding deployment are subject to risks relating to the execution and enforceability of the definitive agreement, hardware supply chain constraints, and facility readiness. If we are unable to deploy contracted infrastructure on the agreed schedule, we may be subject to service credits, penalties, delayed or reduced revenue, customer disputes, termination rights, or reputational harm, any of which could materially and adversely affect our business.

 

 

 

34

 

If customer demand is insufficient to utilize the capacity we build, or if we are unable to redeploy infrastructure following the expiration or termination of a contract, we may not realize the expected returns on our capital investments.

 

The owned-asset model requires us to commit substantial capital to acquire and deploy infrastructure, often in advance of, or in reliance upon, specific customer contracts. Our expected returns depend on sustained customer demand and high utilization of the capacity we build. If a customer reduces its usage, does not renew or terminates its contract, or if we are otherwise unable to redeploy or resell capacity on economically attractive terms following the expiration of an initial contract term, we may experience underutilized capacity, stranded assets, reduced margins, or impairment charges. Because our infrastructure is purpose-built and concentrated, and because GPUs are subject to rapid obsolescence, we may be unable to repurpose assets for other customers or workloads without incurring additional cost or delay. Any failure to achieve sufficient utilization of our owned infrastructure could materially and adversely affect our business, results of operations, and financial condition.

 

We expect to incur indebtedness and to use secured or asset-backed financing structures to fund our infrastructure, and our leverage could adversely affect our financial condition and flexibility.

 

To fund the acquisition of GPU infrastructure, we may incur substantial indebtedness and may pursue secured financing arrangements, including asset-backed, equipment-financing, or other collateralized structures, in which our GPUs and related assets serve as collateral. Companies in our industry carry significant indebtedness and finance GPU purchases through delayed draw term loans, original equipment manufacturer financing arrangements, and similar structures secured by the depreciable cost of GPU servers. A substantial level of indebtedness could require us to dedicate a significant portion of our cash flow to debt service, increase our vulnerability to adverse economic and industry conditions, limit our ability to obtain additional financing, restrict our operational and strategic flexibility through restrictive covenants, and expose us to the risk of acceleration or foreclosure on pledged assets in the event of a default. The management of a more complex capital structure, including multiple layers of secured and unsecured debt with differing covenants, maturities, and priorities, could increase our financial and operational risks and heighten the risk of disputes among creditors. Rising or volatile interest rates would increase the cost of any floating-rate indebtedness, and we may be required to enter into interest rate hedging arrangements that may not be effective.

 

We have a limited operating history operating an owned-infrastructure GPU business, which makes it difficult to evaluate our business and prospects.

 

We have only recently expanded into purchasing, owning, and operating GPU computing infrastructure, and we have a limited operating history under this business model. Our prior compute model was asset-light and distributed, and the owned-infrastructure model requires different capabilities, including the procurement and lifecycle management of hardware, the operation of dedicated data center deployments, the management of large multi-year take-or-pay contracts, and the management of capital-intensive financing. Our limited experience delivering and managing longer-term, large-scale customer contracts may expose us to cost overruns, underutilized capacity, performance obligations, service-level commitments, and other contractual liabilities. As a result, our historical results are not indicative of our future performance, our future results may be difficult to predict and may fluctuate significantly from period to period, and you should consider our business and prospects in light of the risks and uncertainties frequently encountered by companies operating in new and rapidly evolving capital-intensive markets.

 

The energy and environmental demands of data centers and GPU compute infrastructure may constrain the growth of the compute market and result in increased regulatory costs or operational limitations.

 

Data centers are significant consumers of electrical power, and this level of energy consumption has attracted increasing scrutiny from regulators, utilities, and environmental groups, which may result in additional restrictions, permitting requirements, carbon reporting obligations, or energy surcharges that increase the cost of GPU compute infrastructure. Because we will now own and operate GPU computing infrastructure deployed in dedicated data center facilities that require substantial committed power, including 4.8 megawatts of dedicated power for our largest deployment to date, constraints on available power capacity, increases in the cost of power, and new regulatory or environmental requirements directly affect our operating costs and our ability to expand. In addition, reputational and environmental, social, and governance concerns relating to the energy and water footprint of AI compute infrastructure could adversely affect our business relationships, our access to capital, and our ability to obtain permits and approvals.

 

 

 

35

 

Geopolitical tensions and trade restrictions, particularly between the United States and China, could disrupt GPU supply chains and limit our addressable market.

 

The global GPU compute market depends heavily on complex international supply chains, including semiconductor manufacturing concentrated in Taiwan and South Korea, and geopolitical tensions between the United States and China have already resulted in restrictions on the export of certain advanced semiconductors, including certain NVIDIA GPU products. Because we will now own GPU hardware sourced primarily from NVIDIA, geopolitical tensions, tariffs, economic sanctions, and export controls directly affect the cost, availability, and delivery lead times of the GPUs and related components we acquire. Increasing use of tariffs and export controls has impacted, and may in the future impact, the availability and cost of GPUs and other components, and expansion or reinterpretation of U.S. export controls covering advanced computing hardware could limit the availability of components or require reconfiguration of our deployment plans. Any such disruption could increase our procurement costs, delay our deployments, including our targeted third-quarter 2026 deployment, and materially and adversely affect our compute business and our ability to execute our strategy.

 

Demand for GPU compute is highly concentrated, and a slowdown in AI-related spending or the development of excess industry capacity could adversely affect our business.

 

A substantial portion of current and projected demand for GPU compute infrastructure is driven by a small number of large technology companies and government-sponsored AI programs, and any significant reduction in their capital expenditures could have a disproportionately negative impact on the broader GPU compute market. In addition, a substantial portion of our own compute revenue is now expected to be derived from a limited number of customers and contracts, including our recently announced approximately $260 million enterprise engagement. A slowdown, deferral, or reprioritization of AI-related customer spending, or the development of excess industry capacity if anticipated AI workloads do not materialize, could result in pricing pressure, reduced utilization, longer sales cycles, contract renegotiations, or impairment charges, any of which could be magnified by the capital-intensive, owned-asset nature of our expanded business.

 

Advances in AI model efficiency could reduce demand for GPU compute, adversely affecting the value of our compute business and our owned infrastructure.

 

A key driver of demand for GPU compute is the scale required to train and run AI models, and consistent advances in AI model efficiency — such as new architectures, training techniques, or algorithmic improvements that achieve equivalent or superior results using significantly less compute — could substantially reduce demand for raw GPU compute capacity. Because we will own GPU hardware rather than relying solely on a distributed network, a significant and sustained reduction in GPU compute demand could reduce the utilization, pricing, and resale or redeployment value of our owned infrastructure, and could require us to recognize accelerated depreciation or impairment charges, in addition to adversely affecting the value of our ATH treasury holdings.

 

Security breaches and other disruptions affecting our infrastructure or the facilities in which it is housed could compromise sensitive information and expose us to liability.

 

Our business requires that we collect and store sensitive data, and our information technology and infrastructure are susceptible to attacks by hackers, viruses, employee error, malfeasance, or other activities. In addition, our owned GPU computing infrastructure and the data center facilities in which it is deployed are subject to physical and cybersecurity risks, including attacks by outside parties (whether private or state-backed), human error, malfeasance, insider threats, system vulnerabilities, and inadequate security controls, any of which could result in service outages, unauthorized access to or loss of customer data and workloads, or damage to our infrastructure. Our enterprise customers contract for dedicated infrastructure in part to ensure that their proprietary data remains within a controlled facility boundary, and any physical or cybersecurity incident affecting our infrastructure or the facilities in which it is housed could expose us to service-level penalties, contractual liability, loss of customers, regulatory exposure, and reputational harm.

 

 

 

36

 

If our information technology and communications systems, or the infrastructure and facilities on which our compute business depends, fail or experience a significant interruption, our business could be materially and adversely affected.

 

The efficient operation of our business is dependent on information technology and communications systems, the failure of which could disrupt our business and result in decreased revenue and increased overhead costs. Our expanded business further depends on the continuous operation of owned GPU computing infrastructure housed in third-party data center facilities, and the availability and performance of that infrastructure depend on power, cooling, network connectivity, redundancy systems (including N+1 redundant power), and the performance of the third-party operators of the facilities in which our equipment is installed. The failure of any of these systems or services, including any failure of redundancy or disaster recovery measures, could prevent us from meeting contracted service levels and could materially and adversely affect our reputation, business, and results of operations.

 

Our expansion into owned GPU infrastructure has materially increased our capital requirements and our dependence on external financing.

 

We have a history of negative operating cash flows and have funded our operations in part through at-the-market and private placement equity financings, with a significant portion of our liquidity held in ATH, a digital asset whose market price has exhibited substantial volatility. Our expansion into purchasing and owning GPU computing infrastructure has materially increased our capital expenditure requirements and our dependence on external financing, and our liquidity needs are now driven in part by the substantial upfront and ongoing costs of acquiring, deploying, maintaining, and expanding owned hardware and data center capacity. Although our largest contract to date is supported by a customer deposit, prepayment, and monthly in-advance payments on a take-or-pay basis, these amounts may be insufficient to fund our capital requirements, and our reliance on volatile sources of liquidity, including the price of ATH, may further constrain our ability to fund these commitments.

 

 

 

 

 

37

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended June 30, 2026, there were no unregistered sales of securities that were not reported on a Current Report on Form 8-K.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

ITEM 5. OTHER INFORMATION

 

Not applicable.

 

 

ITEM 6. EXHIBITS

 

Exhibit Number

Description

10.1 Employment Agreement, dated April 1, 2026, by and between the Company and Kyle Okamoto (Filed on April 1, 2026 as an exhibit to our Current Report on Form 8-K and incorporated herein by reference.)
10.2 Stock Option Inducement Award Agreement, dated April 1, 2026, by and between the Company and Kyle Okamoto (Filed on April 1, 2026 as an exhibit to our Current Report on Form 8-K and incorporated herein by reference.)
10.3 Employment Agreement, dated April 16, 2026, by and between the Company and Jeremy Yaukey-Witter (Filed on April 16, 2026 as an exhibit to our Current Report on Form 8-K and incorporated herein by reference.)
10.4 Stock Option Inducement Award Agreement, dated April 16, 2026, by and between the Company and Jeremy Yaukey-Witter (Filed on April 16, 2026 as an exhibit to our Current Report on Form 8-K and incorporated herein by reference.)

31.1*

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*

Inline XBRL Instance Document

101.SCH*

Inline XBRL Taxonomy Extension Schema Document

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith

** Furnished herewith

 

38

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

AXE COMPUTE INC.

 
     

Date: August 14, 2026

By:

/s/ Christopher Miglino

 
   

Christopher Miglino

 
   

Chief Executive Officer

 

 

Date: August 14, 2026

By:

/s/ Jeremy Yaukey-Witter

 
   

Jeremy Yaukey-Witter

 
   

Chief Financial Officer

 

 

 

39